13.Disclosures ADA 15.indd

91 Pages·2015·0.87 MB·English

ABSTRACT AUTHOR DISCLOSURE INFORMATION
All presenters/authors are required to disclose to the program audience any fi nancial relationships related to the subject matter of this program. The
intent of this disclosure is not to prevent a presenter or author from being involved in the activity, but rather to provide participants with information on
which they may make their own judgments.
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
A., Ligen ...............................................Disclosed no confl ict of interest. Adachi, Kei ...........................................Disclosed no confl ict of interest.
Aakhus, Svend .....................................Disclosed no confl ict of interest. Adachi, Yasuhiro .................................Disclosed no confl ict of interest.
Aas, Vigdis ...........................................Disclosed no confl ict of interest. Adachi, Yusuke ....................................Disclosed no confl ict of interest.
Abadi, Sakineh E. ................................Disclosed no confl ict of interest. Adams, David B. ..................................Disclosed no confl ict of interest.
Abate, Nicola ......................................Disclosed no confl ict of interest. Adams, Jeneva ....................................Disclosed no confl ict of interest.
Abbott, Scott .......................................Employee: Valeritas. Adams, Jessica M. .............................Disclosed no confl ict of interest.
Abbott, Shaun .....................................Disclosed no confl ict of interest. Adams, Rachel ....................................Disclosed no confl ict of interest.
Abdalla, Mohamed M. ........................Disclosed no confl ict of interest. Adams, Sara R. ....................................Employee: Kaiser Permanente of Northern California;
Abdalla, Moustafa M. ........................Disclosed no confl ict of interest. Research Support: National Institute of Diabetes and
Abdelhameed, Mosaad ......................Disclosed no confl ict of interest. Digestive and Kidney Diseases.
Abdraimova-Meyramova, Aizhan G. ....Disclosed no confl ict of interest. Adamska, Agnieszka ...........................Disclosed no confl ict of interest.
Abdukadier, Abulizi .............................Disclosed no confl ict of interest. Adamska, Edyta ..................................Disclosed no confl ict of interest.
E
R Abdul Murad, Nor Azian .....................Disclosed no confl ict of interest. Addo-Yobo, Charles ............................Disclosed no confl ict of interest.
U Abdul Wahed, Aya ..............................Disclosed no confl ict of interest. Adebamowo, Clement ........................Disclosed no confl ict of interest.
S Abdulhamid, Sarah .............................Disclosed no confl ict of interest. Adel, Heba ...........................................Disclosed no confl ict of interest.
O
L Abdulina, Galiya A. .............................Research Support: Karaganda State Medical University. Adeleye, Jokotade ..............................Disclosed no confl ict of interest.
C Abdullah, Chowdhury S. .....................Disclosed no confl ict of interest. Adeli, Khosrow ....................................Disclosed no confl ict of interest.
S
I Abdullah, Noraidatulakma .................Disclosed no confl ict of interest. Adem, Abdu .........................................Disclosed no confl ict of interest.
D Abdulreda, Midhat H. .........................Disclosed no confl ict of interest. Adetunji, Omolara ...............................Employee: Eli Lilly and Company.
R Abe, Masanori .....................................Disclosed no confl ict of interest. Adeyemo, Adebowale ........................Disclosed no confl ict of interest.
O
Abe, Yoshimi ........................................Disclosed no confl ict of interest. Adi, Saleh ............................................Disclosed no confl ict of interest.
H
T Abedini, Andisheh ...............................Other Relationship: Patent application for the screening of Adkins, Laura .......................................Disclosed no confl ict of interest.
U IAPP toxic intermediates, and co-inventor on a patent Adler, Gail ............................................Disclosed no confl ict of interest.
A application for fl uorescent analogs of h-IAPP. Adorini, Luciano ..................................Disclosed no confl ict of interest.
Abel, E. Dale ........................................Disclosed no confl ict of interest. Advani, Andrew ..................................Advisory Panel: Boehringer Ingelheim Pharmaceuticals,
Abellán, Pablo .....................................Disclosed no confl ict of interest. Inc., Novo Nordisk A/S; Consultant: Novo Nordisk A/S;
Abels, Mia ...........................................Disclosed no confl ict of interest. Other Relationship: AstraZeneca Pharmaceuticals LP;
Abelson, Jamie ...................................Disclosed no confl ict of interest. Research Support: Boehringer Ingelheim GmbH, Novo
Aberer, Felix ........................................Disclosed no confl ict of interest. Nordisk A/S.
Abiko, Atsuko ......................................Consultant: Novo Nordisk Inc., Ono Pharmaceutical Co., Afanasyev, Dmitriy Y. .........................Disclosed no confl ict of interest.
Ltd.; Speaker’s Bureau: Astellas Pharma US, Inc., Afek, Arnon .........................................Disclosed no confl ict of interest.
AstraZeneca Pharmaceuticals LP, Bayer HealthCare, Affarah, Lynn .......................................Disclosed no confl ict of interest.
Daiichi-Sankyo Co., Ltd., Eli Lilly Japan K.K., Kowa Afi fi , Nahla M. .....................................Disclosed no confl ict of interest.
Pharmaceuticals, Merck Sharp & Dohme, Nippon Afonso, Milessa S. ..............................Disclosed no confl ict of interest.
Boehringer Ingelheim Co., Ltd., Novartis Corporation, Agakov, Felix .......................................Other Relationship: Stakeholder in Pharmatics Ltd.
Novo Nordisk Inc., Sanofi U.S., Taisho Pharmaceutical Agardh, Daniel ....................................Disclosed no confl ict of interest.
Co., Ltd., Takeda Pharmaceutical Company Limited. Agarwal, Mukesh M. ..........................Disclosed no confl ict of interest.
Abiru, Akiko .........................................Employee: Takeda Pharmaceutical Company Limited. Agbakoba, Nneka R. ...........................Disclosed no confl ict of interest.
Abolfotouh, Mostafa A. .....................Disclosed no confl ict of interest. Agee, Susan C. ....................................Disclosed no confl ict of interest.
Abood, Beth .........................................Disclosed no confl ict of interest. Agle, Steven Carl ................................Disclosed no confl ict of interest.
Abouzaid, Mona ..................................Disclosed no confl ict of interest. Aglione, Johnpaul ...............................Employee: Regeneron Pharmaceuticals, Inc.
Abrahamsen, Trine Julie ....................Employee: Novo Nordisk A/S. Agoram, Balaji .....................................Employee: MedImmune, Inc.
Abrahamson, Martin J. ......................Advisory Panel: Halozyme Therapeutics, Janssen Agosti, Barbara ...................................Disclosed no confl ict of interest.
Pharmaceutical Companies of Johnson & Johnson, Agostini, Lebaron ................................Disclosed no confl ict of interest.
Novo Nordisk Inc., WebMD; Research Support: Agrawal, Pankaj ..................................Disclosed no confl ict of interest.
Metagenics, Inc. Agrawal, Rajendra P. ..........................Disclosed no confl ict of interest.
Abrahamsson, Niclas ..........................Disclosed no confl ict of interest. Aguayo-Mazzucato, Cristina ..............Disclosed no confl ict of interest.
Abramowitz, Jessica ..........................Disclosed no confl ict of interest. Aguilar, David ......................................Disclosed no confl ict of interest.
Abreu, Damien ....................................Disclosed no confl ict of interest. Aguilar, Montserrat ............................Disclosed no confl ict of interest.
Abreu, Maria M. ..................................Disclosed no confl ict of interest. Aguilar-Diosdado, Manuel .................Disclosed no confl ict of interest.
Abribat, Thierry ...................................Board Member: Alize Pharma; Employee: Alize Pharma; Aguilar-Jiménez, Miriam ....................Disclosed no confl ict of interest.
Stock/Shareholder: Alize Pharma. Aguilar-Salinas, Carlos .......................Disclosed no confl ict of interest.
Abu Bakar, Mohamad Hafi zi ...............Disclosed no confl ict of interest. Aguirre-Sánchez-Covisa, Miguel .......Disclosed no confl ict of interest.
Abuaysheh, Sanaa ..............................Disclosed no confl ict of interest. Agus, Michael .....................................Consultant: Roche Diagnostics; Research Support: Dexcom,
Abubaker, Jehad .................................Disclosed no confl ict of interest. Inc., Edwards Scientifi c, NOVA Biomedical.
Abuduli, Maerjianghan .......................Disclosed no confl ict of interest. Agyenim-Boateng, Kofi .......................Disclosed no confl ict of interest.
Abu-Farha, Mohamed .........................Disclosed no confl ict of interest. Ahima, Rexford S. ...............................Disclosed no confl ict of interest.
Abulizi, Abudukadier ...........................Disclosed no confl ict of interest. Ahlkvist, Linda .....................................Disclosed no confl ict of interest.
Abumrad, Naji N. ................................Disclosed no confl ict of interest. Ahlqvist, Emma ...................................Disclosed no confl ict of interest.
Aburima, Ahmed .................................Disclosed no confl ict of interest. Ahluwalia, Tarunveer S. .....................Disclosed no confl ict of interest.
Accili, Domenico .................................Disclosed no confl ict of interest. Ahmann, Andrew J. ............................Disclosed no confl ict of interest.
Accogli, Andrea ...................................Disclosed no confl ict of interest. Ahn, Chang Ho .....................................Disclosed no confl ict of interest.
Acerini, Carlo L. ...................................Disclosed no confl ict of interest. Ahn, Chul Woo ....................................Disclosed no confl ict of interest.
Acheampong, Joseph .........................Disclosed no confl ict of interest. Ahn, Jae Hee .......................................Disclosed no confl ict of interest.
Ackart, David .......................................Disclosed no confl ict of interest. Ahn, Jee Hyun .....................................Disclosed no confl ict of interest.
Ackermann, Ronald T. .........................Disclosed no confl ict of interest. Ahn, Jin Hee ........................................Disclosed no confl ict of interest.
Ackermans, Mariette T. ......................Disclosed no confl ict of interest. Ahn, Kang Hee .....................................Disclosed no confl ict of interest.
Acord, Chelsea R. ................................Disclosed no confl ict of interest. Ahn, Kyu Jeung ...................................Disclosed no confl ict of interest.
Acosta-Delgado, Domingo .................Disclosed no confl ict of interest. Ahn, Sylvie A. ......................................Disclosed no confl ict of interest.
Acton, Anthony J. ...............................Disclosed no confl ict of interest. Ahn, Yu-Bae .........................................Disclosed no confl ict of interest.
Acusta, Andre P. ..................................Employee: GlaxoSmithKline; Stock/Shareholder: Ahrén, Bo .............................................Advisory Panel: Merck Sharp & Dohme, Novartis Pharma
GlaxoSmithKline. GmbH, Novo Nordisk A/S, Sanofi U.S., Takeda
A810
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
Pharmaceutical Company Limited; Speaker’s Bureau: Ali, Aktar ..............................................Disclosed no confl ict of interest.
AstraZeneca Pharmaceuticals LP, Merck Sharp & Ali, Mohammed K. ..............................Research Support: National Institute of Diabetes and
Dohme, Novartis Pharma GmbH, Novo Nordisk A/S. Digestive and Kidney Diseases.
Ahroni, Jessie H. .................................Disclosed no confl ict of interest. Ali, Safi na ............................................Disclosed no confl ict of interest.
Aida, Eri ...............................................Disclosed no confl ict of interest. Al-Ibraheemi, Zainab ..........................Disclosed no confl ict of interest.
Aiello, Lloyd M. ...................................Disclosed no confl ict of interest. Alkanani, Aimon ..................................Disclosed no confl ict of interest.
Aiello, Lloyd P. .....................................Advisory Panel: Foreseehome, Genzyme Corporation, Al-Khairi, Irina .....................................Disclosed no confl ict of interest.
KalVista Pharmaceuticals Inc.; Consultant: Opthotech, Allard, Camille .....................................Disclosed no confl ict of interest.
Sanovas, ThromboGenics; Other Relationship: Optos plc. Allas, Soraya .......................................Employee: Alize Pharma; Stock/Shareholder: Alize Pharma.
Aiello, Vito ...........................................Disclosed no confl ict of interest. Allayee, Hooman .................................Disclosed no confl ict of interest.
Aigner, Elmar .......................................Disclosed no confl ict of interest. Allen, Isabel E. ....................................Disclosed no confl ict of interest.
Aihara, Haruna ....................................Disclosed no confl ict of interest. Allen, Janet M. ....................................Disclosed no confl ict of interest.
Aihara, Ken-Ichi ..................................Disclosed no confl ict of interest. Allen, Terri ...........................................Disclosed no confl ict of interest.
Aitken, Karen .......................................Disclosed no confl ict of interest. Allenback, Gayle .................................Disclosed no confl ict of interest.
Aitkulov, Aidar M. ...............................Disclosed no confl ict of interest. Aller, Rocio ..........................................Disclosed no confl ict of interest.
Aizawa, Toru ........................................Disclosed no confl ict of interest. Allison, Matthew ................................Disclosed no confl ict of interest.
Ajai, Neethu A. ....................................Disclosed no confl ict of interest. Allister, Emma M. ................................Disclosed no confl ict of interest.
Ajay, Vamadevan S. ............................Disclosed no confl ict of interest. Alluis, Bertrand ...................................Employee: Adocia; Stock/Shareholder: Adocia.
Ajluni, Nevin ........................................Disclosed no confl ict of interest. Almahmeed, Buthaina ........................Disclosed no confl ict of interest.
Akai, Yasuhiro .....................................Disclosed no confl ict of interest. Alman, Amy .........................................Disclosed no confl ict of interest.
Akamatsu, Yosuke ..............................Disclosed no confl ict of interest. Al-Maqbali, Ali ....................................Other Relationship: Johnson & Johnson, Merck Sharp &
Akamizu, Takashi ................................Disclosed no confl ict of interest. Dohme, Novartis Pharmaceuticals Corporation.
E
Akanuma, Yasuo ..................................Disclosed no confl ict of interest. Almario, Rogelio ..................................Disclosed no confl ict of interest. R
Akasu, Shoko .......................................Disclosed no confl ict of interest. Almasy, Laura ......................................Disclosed no confl ict of interest. U
S
Akcicek, Fehmi ....................................Disclosed no confl ict of interest. Almdal, Thomas ..................................Stock/Shareholder: Novo Nordisk A/S.
O
Akel, Bridget ........................................Disclosed no confl ict of interest. Almeda-Valdez, Paloma ......................Disclosed no confl ict of interest. L
Akeroyd, Julia .....................................Disclosed no confl ict of interest. Almeida, Fabio A. ................................Disclosed no confl ict of interest. C
S
Akhmetova, Saule B. ..........................Research Support: Karaganda State Medical University. Almeida-Pititto, Bianca ......................Disclosed no confl ict of interest. I
Akhter, Jaweed ...................................Disclosed no confl ict of interest. Almgren, Peter ....................................Disclosed no confl ict of interest. D
Aki, Nanako .........................................Disclosed no confl ict of interest. Al-Mrabeh, Ahmad .............................Disclosed no confl ict of interest. R
O
Aki, Saito .............................................Disclosed no confl ict of interest. Aloi, Joseph .........................................Disclosed no confl ict of interest. H
Akihisa, Momoko ................................Disclosed no confl ict of interest. Alon, Tal ...............................................Employee: Insuline Medical Ltd. T
Akimoto, Yoshiro .................................Disclosed no confl ict of interest. Alonso, Laura C. ..................................Disclosed no confl ict of interest. U
Akinseye, Leah I. .................................Disclosed no confl ict of interest. Alonzo, Ryan ........................................Disclosed no confl ict of interest. A
Akinseye, Oluwaseun A. ....................Disclosed no confl ict of interest. Alpha, David ........................................Disclosed no confl ict of interest.
Akiyama, Masaru ................................Disclosed no confl ict of interest. Alqarzaee, Abdulelah .........................Disclosed no confl ict of interest.
Akiyama, Taro .....................................Employee: Merck & Co., Inc. Al-Rasadi, Khalid ................................Other Relationship: Abbott, Aegerion Pharmaceuticals, Inc.,
Akiyama, Yoshitaka ............................Disclosed no confl ict of interest. AstraZeneca Pharmaceuticals LP, Pfi zer Inc.
Akkermans, Reinier P. .........................Disclosed no confl ict of interest. Alrasheed, Nawal M. .........................Disclosed no confl ict of interest.
Akolkar, Beena ....................................Disclosed no confl ict of interest. Alrasheed, Nouf M. ............................Disclosed no confl ict of interest.
Aktas¸, Serife .......................................Disclosed no confl ict of interest. Alsadun, Sarah ....................................Disclosed no confl ict of interest.
Al Araj, Sumayya ................................Research Support: Novo Nordisk A/S. Alsaheel, Abdulhameed .....................Disclosed no confl ict of interest.
Al Busaidi, Noor ..................................Disclosed no confl ict of interest. Alshehabi, Erica ..................................Disclosed no confl ict of interest.
Al Sayah, Fatima .................................Disclosed no confl ict of interest. Alsifri, Saud N. ....................................Disclosed no confl ict of interest.
Alafi fi , Jamal .......................................Disclosed no confl ict of interest. Altaf, Faseeha K. .................................Disclosed no confl ict of interest.
Alagol, Faruk .......................................Disclosed no confl ict of interest. Alter, Markus L. ...................................Disclosed no confl ict of interest.
Al-Ajmi, Hanaa N. ...............................Disclosed no confl ict of interest. Altschul, Randiece L. ..........................Advisory Panel: PopTest LLC; Board Member: PopTest LLC;
Alam, Maqsood ...................................Disclosed no confl ict of interest. Employee: PopTest LLC.
Alam, Uazman .....................................Disclosed no confl ict of interest. Altschuler, Andrea ..............................Disclosed no confl ict of interest.
Al-Amin, Maha A. ...............................Disclosed no confl ict of interest. Altshuler, David M. .............................Disclosed no confl ict of interest.
Alarcon, Javier ....................................Employee: Becton, Dickinson and Company. Alunno, Alessia ...................................Disclosed no confl ict of interest.
Al-Arouj, Monira .................................Disclosed no confl ict of interest. Alvarez Fallas, Mario Enrique ............Disclosed no confl ict of interest.
Alawieh, Mohamad ............................Disclosed no confl ict of interest. Alvarez, Andrea ..................................Disclosed no confl ict of interest.
Albai, Alin ............................................Disclosed no confl ict of interest. Alvarez-Perez, Juan C. ........................Disclosed no confl ict of interest.
Albai, Oana ..........................................Disclosed no confl ict of interest. Alvarez-Viejo, Maria ...........................Disclosed no confl ict of interest.
Albarrak, Abdulmajeed .......................Disclosed no confl ict of interest. Alvarsson, Michael .............................Advisory Panel: AstraZeneca Pharmaceuticals LP, Eli Lilly
Albaugh, Vance L. ...............................Disclosed no confl ict of interest. and Company, Novo Nordisk Inc., Sanofi U.S.; Speaker’s
Albrecht, Diego ...................................Employee: Novartis AG; Stock/Shareholder: Novartis AG. Bureau: Eli Lilly and Company, Novo Nordisk Inc., Sanofi
Albrecht, Tobias ..................................Disclosed no confl ict of interest. U.S.
Albrechtsen, Reidar ............................Disclosed no confl ict of interest. Alves, Tiago C. ....................................Disclosed no confl ict of interest.
Albright, Ann L. ...................................Disclosed no confl ict of interest. Al-Waili, Khalid ...................................Disclosed no confl ict of interest.
Alcaide-Torres, Juan ...........................Disclosed no confl ict of interest. Amaral, Cláudia ...................................Disclosed no confl ict of interest.
Aldana, Paola C. ..................................Disclosed no confl ict of interest. Amarnani, Dhanesh S. ........................Disclosed no confl ict of interest.
Alderisio, Antonio ...............................Disclosed no confl ict of interest. Ambrosino, Jodie M. ..........................Disclosed no confl ict of interest.
Aldini, Giancarlo ..................................Disclosed no confl ict of interest. Ametov, Alexander .............................Disclosed no confl ict of interest.
Aldossari, Khaled K. ...........................Disclosed no confl ict of interest. Amiel, Stephanie A. ............................Disclosed no confl ict of interest.
Alejandro, Emilyn ................................Disclosed no confl ict of interest. Amini, Sam ..........................................Disclosed no confl ict of interest.
Alejandro, Rodolfo ..............................Disclosed no confl ict of interest. Amir Levy, Yifat ...................................Disclosed no confl ict of interest.
Alemany, Pedro Maria ........................Disclosed no confl ict of interest. Amital, Daniela ...................................Disclosed no confl ict of interest.
Aleppo, Grazia .....................................Disclosed no confl ict of interest. Amital, Howard ...................................Disclosed no confl ict of interest.
Alessi, Tom ..........................................Disclosed no confl ict of interest. Ammons, Ann ......................................Disclosed no confl ict of interest.
Aletras, Vassilis H. ..............................Disclosed no confl ict of interest. Ammori, Basil ......................................Disclosed no confl ict of interest.
Alexander, Jamin ................................Disclosed no confl ict of interest. Amoah, Albert .....................................Disclosed no confl ict of interest.
Alexander-Chacko, Jesline T. .............Employee: Eli Lilly and Company. Amor, Paul A. .......................................Employee: Pfi zer Inc.
Alexanian, Sara ...................................Disclosed no confl ict of interest. Amoussou-Guenou, K. Daniel ............Disclosed no confl ict of interest.
Alfaro, Freddy ......................................Disclosed no confl ict of interest. Amouzegar, Atieh ................................Disclosed no confl ict of interest.
Alfonso Ross Terres, Jorge ................Employee: GlaxoSmithKline; Stock/Shareholder: Ampudia-Blasco, Francisco J. ............Advisory Panel: Sanofi .
GlaxoSmithKline. Amrani, Abdelaziz ...............................Disclosed no confl ict of interest.
Algatt-Bergstrom, Pamela .................Employee: Merck & Co., Inc.; Stock/Shareholder: Merck & Amundson, Gerald H. ..........................Disclosed no confl ict of interest.
Co., Inc. An, Hyun Ju .........................................Disclosed no confl ict of interest.
Alharbi, Majed A. ................................Disclosed no confl ict of interest. An, JaeJin ...........................................Research Support: Genentech, Inc.
Al-Hasani, Hadi ...................................Disclosed no confl ict of interest. An, Jee Hyun .......................................Disclosed no confl ict of interest.
A811
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
An, Ping ................................................Disclosed no confl ict of interest. Araki, Eiichi ..........................................Disclosed no confl ict of interest.
An, Seung Min .....................................Disclosed no confl ict of interest. Araki, Shin-Ichi ....................................Disclosed no confl ict of interest.
An, So-Yeon .........................................Disclosed no confl ict of interest. Aranda, Cristina ..................................Employee: Sanofi Aventis S.A.
An, Yali .................................................Disclosed no confl ict of interest. Arase, Yasuji .......................................Disclosed no confl ict of interest.
Anand, Praveen ...................................Disclosed no confl ict of interest. Arathuzik, Gillian .................................Disclosed no confl ict of interest.
Andel, Michal ......................................Disclosed no confl ict of interest. Araujo, Debora B. ................................Disclosed no confl ict of interest.
Andersen, Birgitte ..............................Employee: Novo Nordisk A/S. Araujo, Fabiana ...................................Disclosed no confl ict of interest.
Andersen, Charles ..............................Disclosed no confl ict of interest. Araújo, Thiago .....................................Disclosed no confl ict of interest.
Andersen, Emilie S. .............................Disclosed no confl ict of interest. Araujo-Vilar, David ..............................Consultant: AstraZeneca/Bristol-Myers Squibb.
Andersen, Grit .....................................Disclosed no confl ict of interest. Arbelaez, Ana Maria ...........................Disclosed no confl ict of interest.
Andersen, Henrik U. ............................Advisory Panel: Abbott; Employee: Steno Diabetes Center Arbit, Ehud ...........................................Consultant: Oramed Pharmaceuticals.
A/S; Stock/Shareholder: Novo Nordisk A/S. Arboleda-Velasquez, Joseph F. ..........Disclosed no confl ict of interest.
Andersen, Steen .................................Disclosed no confl ict of interest. Arena, Vincent C. ................................Disclosed no confl ict of interest.
Anderson, Barbara J. ..........................Advisory Panel: Sanofi U.S.; Consultant: The Leona M. and Arends, Derk ........................................Disclosed no confl ict of interest.
Harry B. Helmsley Charitable Trust; Research Support: Arends, Valerie ....................................Disclosed no confl ict of interest.
Juvenile Diabetes Research Foundation, National Argento, Nicholas B. ...........................Advisory Panel: BD Medical-Diabetes Care, Eli Lilly and
Institutes of Health. Company, Janssen Pharmaceutical Companies of
Anderson, Brian ..................................Disclosed no confl ict of interest. Johnson & Johnson, Roche USA; Consultant: Animas
Anderson, Jessica ..............................Disclosed no confl ict of interest. Corporation, Johnson and Johnson Diabetes Institute;
Anderson, Lise Lotte ...........................Disclosed no confl ict of interest. Research Support: Dexcom, Inc.; Speaker’s Bureau:
Anderson, Simon G. ............................Disclosed no confl ict of interest. Animas Corporation, AstraZeneca Pharmaceuticals LP,
Anderson, Stacey ................................Consultant: Senseonics; Research Support: Dexcom, Inc., Boehringer Ingelheim Pharmaceuticals, Inc., Dexcom,
E
R Medtronic, Inc., Roche USA. Inc., Eli Lilly and Company, Janssen Pharmaceutical
U Anderson, Stewart J. .........................Disclosed no confl ict of interest. Companies of Johnson & Johnson, Novo Nordisk Inc.
S
Andersson, Gert S. ..............................Disclosed no confl ict of interest. Ari, Csilla .............................................Disclosed no confl ict of interest.
O
L Andersson, Lotta ................................Disclosed no confl ict of interest. Arita, Mikio .........................................Disclosed no confl ict of interest.
C Ando, Kiyotaka ....................................Disclosed no confl ict of interest. Ariyachet, Chaiyaboot ........................Disclosed no confl ict of interest.
S
I Ando, Ryotaro .....................................Employee: Kurume University School of Medicine. Arky, Ronald A. ....................................Disclosed no confl ict of interest.
D Andrade, Sara .....................................Disclosed no confl ict of interest. Armas, Danielle ...................................Employee: Celerion, Inc.
R Andre, Anthony D. ...............................Consultant: GlaxoSmithKline. Armistead, Niti S. ...............................Disclosed no confl ict of interest.
O
H Andreasen, Camilla .............................Disclosed no confl ict of interest. Armstrong, Loren ................................Disclosed no confl ict of interest.
T Andreassen, Kim V. .............................Employee: Nordic Bioscience. Arnold, Amy C. ....................................Disclosed no confl ict of interest.
U Andreoli, Christopher .........................Disclosed no confl ict of interest. Arnold, Lindsay ...................................Disclosed no confl ict of interest.
A Andreoni, Luca ....................................Disclosed no confl ict of interest. Arnold, Lindsay M. ..............................Disclosed no confl ict of interest.
Andrews, David M. .............................Disclosed no confl ict of interest. Arnold, Susan ......................................Employee: PhaseBio Pharmaceuticals, Inc.; Stock/
Andrews, James C. .............................Disclosed no confl ict of interest. Shareholder: PhaseBio Pharmaceuticals, Inc.
Andrikopoulos, Sof .............................Research Support: AstraZeneca/Bristol-Myers Squibb. Aro Guardia, Pedro A. .........................Disclosed no confl ict of interest.
Andrulli Buccheri, Valentina ..............Disclosed no confl ict of interest. Aroda, Vanita R. ..................................Consultant: Novo Nordisk A/S, Sanofi U.S.; Research
Andrzejewski, Danielle .......................Disclosed no confl ict of interest. Support: Amylin Pharmaceuticals, LLC., AstraZeneca
Ang, Lynn .............................................Disclosed no confl ict of interest. Pharmaceuticals LP, Boehringer Ingelheim GmbH, Eisai
Ang, Wei ..............................................Disclosed no confl ict of interest. Co., Ltd., Hanmi, Novo Nordisk A/S, Sanofi U.S., Takeda
Angeletti, Silvia ..................................Disclosed no confl ict of interest. Pharmaceutical Company Limited.
Angelucci, Ermanno ............................Disclosed no confl ict of interest. Aron, David C. .....................................Disclosed no confl ict of interest.
Anghel, Valentin ..................................Disclosed no confl ict of interest. Aronson, Ronnie ..................................Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol-
Anglin, Greg .........................................Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly Myers Squibb Company, Janssen Pharmaceutical
and Company. Companies of Johnson & Johnson, Janssen
Angueira, Anthony ..............................Disclosed no confl ict of interest. Pharmaceuticals, Medtronic, Inc., Novo Nordisk A/S,
Anhe, Gabriel F. ...................................Disclosed no confl ict of interest. Sanofi U.S., Takeda Pharmaceutical Company Limited;
Anhut, Jennifer L. ...............................Disclosed no confl ict of interest. Consultant: AstraZeneca Pharmaceuticals LP, Bristol-
Anichini, Roberto ................................Disclosed no confl ict of interest. Myers Squibb Company, Janssen Pharmaceutical
Anjana, Ranjit M. ................................Disclosed no confl ict of interest. Companies of Johnson & Johnson, Medtronic, Inc.,
Annamalai, Mani .................................Disclosed no confl ict of interest. Novo Nordisk A/S, Sanofi U.S., Takeda Pharmaceutical
Annamalai, Palam ...............................Disclosed no confl ict of interest. Company Limited; Other Relationship: Sanofi U.S.,
Annunziata, Kathy ...............................Consultant: Employee at Kantar Health, working as a Takeda Pharmaceutical Company Limited; Research
consultant with Takeda. Support: AbbVie, AstraZeneca Pharmaceuticals LP,
Annuzzi, Giovanni ................................Disclosed no confl ict of interest. Bristol-Myers Squibb Company, Covance, Eisai Co., Ltd.,
Anokye-Danso, Fred ...........................Disclosed no confl ict of interest. Eli Lilly and Company, Genkyotex, GlaxoSmithKline,
Anthony, Sarah M. ..............................Disclosed no confl ict of interest. ICON plc., Inventive Health, Janssen Inc, Joslin
Antinozzi, Peter ...................................Disclosed no confl ict of interest. Diabetes, Medpace, Medtronic, Inc., Merck & Co., Inc.,
Antonenko, Viktoriia ...........................Disclosed no confl ict of interest. Novo Nordisk A/S, Parexel, Pfi zer Inc., PPD, Quintiles
Antoun, Joseph ...................................Disclosed no confl ict of interest. Inc., Regeneron Pharmaceuticals, Inc., Retrophin,
Antunes, Manuel ................................Disclosed no confl ict of interest. RhoWorld, Sanofi U.S., Takeda Pharmaceutical
Anupunpisit, Vipavee .........................Disclosed no confl ict of interest. Company Limited, WCT and TIMI Group; Speaker’s
Anyfanti, Panagiota ............................Disclosed no confl ict of interest. Bureau: Bristol-Myers Squibb Company.
Anzalone, Deborah .............................Employee: AstraZeneca Pharmaceuticals LP. Aroor, Annayya R. ...............................Disclosed no confl ict of interest.
Aoki, Chie .............................................Disclosed no confl ict of interest. Arora, Shilpkumar ...............................Disclosed no confl ict of interest.
Aoki, Ema .............................................Disclosed no confl ict of interest. Arredouani, Abdelilah .........................Disclosed no confl ict of interest.
Aoki, Masako ......................................Disclosed no confl ict of interest. Arregui-Reyes, Marcela .....................Disclosed no confl ict of interest.
Aomo, Mayumi ....................................Disclosed no confl ict of interest. Arriga, Roberto ...................................Disclosed no confl ict of interest.
Aono, Mayumi .....................................Disclosed no confl ict of interest. Arroba, Ana I. ......................................Disclosed no confl ict of interest.
Aono, Shigeo .......................................Disclosed no confl ict of interest. Arruda-Marques, Maria do Carmo ....Disclosed no confl ict of interest.
Aoun, Charlie .......................................Disclosed no confl ict of interest. Arslanian, Silva A. ..............................Disclosed no confl ict of interest.
Apodaca, Timothy ...............................Disclosed no confl ict of interest. Arthur, Susan ......................................Employee: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc.
Apostolopoulou, Maria .......................Disclosed no confl ict of interest. Arthurs, Blake .....................................Disclosed no confl ict of interest.
Apostolou, Ourania .............................Disclosed no confl ict of interest. Artuso, Rosangela ..............................Disclosed no confl ict of interest.
Apovian, Caroline M. ..........................Research Support: National Institute of Diabetes and Arulmoli, Gowri ...................................Disclosed no confl ict of interest.
Digestive and Kidney Diseases, National Institutes of Arumugam, Somasundaran ................Disclosed no confl ict of interest.
Health. Arvan, Peter ........................................Disclosed no confl ict of interest.
Appana, Deepika .................................Disclosed no confl ict of interest. Aryal, Pratik .........................................Disclosed no confl ict of interest.
Appelt, Dieter ......................................Disclosed no confl ict of interest. Asada, Mariko .....................................Disclosed no confl ict of interest.
Apuzzo, Roberto ..................................Disclosed no confl ict of interest. Asahara, Shun-Ichiro ..........................Disclosed no confl ict of interest.
Araki, Atsushi ......................................Disclosed no confl ict of interest. Asahina, Takayuki ...............................Disclosed no confl ict of interest.
A812
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
Asaka, Hiroyuki ...................................Disclosed no confl ict of interest. Azar, Sami ............................................Advisory Panel: Janssen Research & Development LLC,
Asano, Motochika ...............................Disclosed no confl ict of interest. Merck Sharp & Dohme, Novartis Pharmaceuticals
Asano, Tomoichiro ..............................Disclosed no confl ict of interest. Corporation, Novo Nordisk A/S, Sanofi -Aventis.
Asao, Keiko ..........................................Disclosed no confl ict of interest. Azeem, Rehan .....................................Employee: Intarcia Therapeutics, Inc.
Asare Bediako, Isaac ..........................Disclosed no confl ict of interest. Azevedo, Mirela J. ..............................Disclosed no confl ict of interest.
Asatiani, Natalia G. ............................Disclosed no confl ict of interest. Azhar, Salman .....................................Research Support: Artery Therapeutics.
Asato, Tadashi .....................................Disclosed no confl ict of interest. Azharuddin K.O., Mohammed ............Disclosed no confl ict of interest.
Ascencio-Montiel, Iván de Jesús ......Disclosed no confl ict of interest. Azinheira, Jorge ..................................Disclosed no confl ict of interest.
Ascher-Svanum, Haya ........................Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly Azizi, Fereidoun ...................................Disclosed no confl ict of interest.
and Company. Azizi, Paymon M. .................................Disclosed no confl ict of interest.
Asghar, Ali ...........................................Disclosed no confl ict of interest. Azmi, Shazli .........................................Disclosed no confl ict of interest.
Asghar, Omar .......................................Disclosed no confl ict of interest. Azuma, Nobuyuki ................................Disclosed no confl ict of interest.
Asha, Hesarghatta Shyamasunder ....Disclosed no confl ict of interest. Azzano, Silvana ...................................Disclosed no confl ict of interest.
Ashe, Maureen ....................................Disclosed no confl ict of interest. B. Vera, Nicolas ...................................Disclosed no confl ict of interest.
Ashford, Michael ................................Disclosed no confl ict of interest. Ba, Fatou ..............................................Disclosed no confl ict of interest.
Ashley, Jane ........................................Disclosed no confl ict of interest. Babar, Neelofur ...................................Disclosed no confl ict of interest.
Asik, Mehmet ......................................Disclosed no confl ict of interest. Bacak, Stephen J. ...............................Disclosed no confl ict of interest.
Askin, Gulce .........................................Disclosed no confl ict of interest. Bach, Ermina ........................................Disclosed no confl ict of interest.
Askins, Nissa .......................................Disclosed no confl ict of interest. Bach, Leon ...........................................Disclosed no confl ict of interest.
Aslam, Nadeem ...................................Consultant: Boehringer Ingelheim Pharmaceuticals, Bacha, Fida ..........................................Disclosed no confl ict of interest.
Inc., Sanofi U.S.; Research Support: AstraZeneca/ Bachmann, Martin ..............................Stock/Shareholder: Cytos Biotechnology AG.
Bristol-Myers Squibb, Eli Lilly and Company, Isis Backus, Carey ......................................Disclosed no confl ict of interest.
E
Pharmaceuticals, Inc., Janssen Pharmaceutical Baculescu, Nicoleta ............................Disclosed no confl ict of interest. R
Companies of Johnson & Johnson, Merck & Co., Inc., Bader, Angela ......................................Disclosed no confl ict of interest. U
S
Novo Nordisk Inc., Sanofi U.S. Bader, Erik ............................................Disclosed no confl ict of interest.
O
Asmar, Ali ............................................Disclosed no confl ict of interest. Bader, Giovanni ...................................Employee: Novartis Pharma AG. L
Asmar, Meena .....................................Disclosed no confl ict of interest. Bae, Jaehyun .......................................Disclosed no confl ict of interest. C
S
Aso, Yoshimasa ...................................Disclosed no confl ict of interest. Bae, Jay P. ............................................Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly I
Asp, Lauren L. ......................................Disclosed no confl ict of interest. and Company. D
Aspelund, Thor Aspelund ...................Stock/Shareholder: Risk Medical Solutions. Bae, Ji Cheol .......................................Disclosed no confl ict of interest. R
O
Aspholm, Susanna ..............................Employee: Novo Nordisk Farma. Bae, Myung Ae ....................................Disclosed no confl ict of interest. H
Asplund, Olof .......................................Disclosed no confl ict of interest. Baek, HongSun ....................................Disclosed no confl ict of interest. T
Assaly, Rana ........................................Research Support: Boehringer Ingelheim Pharmaceuticals, Baek, YoungHa ....................................Disclosed no confl ict of interest. U
Inc. Baez, Eileen .........................................Disclosed no confl ict of interest. A
Atageldiyeva, Kuralay K. ....................Disclosed no confl ict of interest. Bagger, Jonatan I. ...............................Disclosed no confl ict of interest.
Atakov-Castillo, Astrid .......................Disclosed no confl ict of interest. Bagiella, Emilia ....................................Disclosed no confl ict of interest.
Ataseven, Huseyin ..............................Disclosed no confl ict of interest. Bagwell, Benjamin M. ........................Disclosed no confl ict of interest.
Atherley, Anique .................................Disclosed no confl ict of interest. Bahaee, Jamsheed .............................Disclosed no confl ict of interest.
Atisso, Charles M. ..............................Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly Bahendeka, Silver K. ...........................Disclosed no confl ict of interest.
and Company. Bahne, Emile ........................................Disclosed no confl ict of interest.
Atkin, Stephen L. .................................Disclosed no confl ict of interest. Bai, Fan ................................................Disclosed no confl ict of interest.
Atkinson, Mark A. ...............................Disclosed no confl ict of interest. Bai, Johnny-Wei ..................................Disclosed no confl ict of interest.
Atlas, Eran ...........................................Disclosed no confl ict of interest. Bai, Juli ................................................Disclosed no confl ict of interest.
Atlas, Steven J. ...................................Disclosed no confl ict of interest. Baier, Leslie J. .....................................Disclosed no confl ict of interest.
Atsuda, Koichiro ..................................Disclosed no confl ict of interest. Baig, Arshiya A. ..................................Research Support: AHQR, National Institutes of Health.
Atsumi, Yoshihito ................................Speaker’s Bureau: Eli Lilly Japan K.K., Johnson & Johnson, Baig, Sonia ...........................................Disclosed no confl ict of interest.
Medtronic, Inc., Novo Nordisk Inc., Ono Pharmaceutical Baik, Sei Hyun .....................................Disclosed no confl ict of interest.
Co., Ltd. Bailbé, Danielle ...................................Disclosed no confl ict of interest.
Attaoua, Redha ...................................Disclosed no confl ict of interest. Bailey, Clifford J. .................................Disclosed no confl ict of interest.
Attia, John ...........................................Disclosed no confl ict of interest. Bailey, James E. ..................................Disclosed no confl ict of interest.
Attinger, Christopher E. ......................Disclosed no confl ict of interest. Bailey, Robert A. .................................Employee: Janssen Pharmaceutical Companies of Johnson
Atto, Zaid .............................................Disclosed no confl ict of interest. & Johnson.
Attucks, Otis C. ...................................Employee: TransTech Pharma, LLC. Bailey, Timothy S. ...............................Consultant: AstraZeneca Pharmaceuticals LP, Bayer
Audibert, Francois ...............................Disclosed no confl ict of interest. HealthCare, BD Medical-Diabetes Care, Lilly
Auer, Simon .........................................Disclosed no confl ict of interest. Deutschland GmbH, Medtronic, Inc., Novo Nordisk Inc.,
Augustin, Robert .................................Disclosed no confl ict of interest. Sanofi U.S.; Research Support: Abbott Laboratories,
Augustin, Thomas ...............................Disclosed no confl ict of interest. Inc., ACON, Alere, Animas Corporation, Bayer
Aukrust, Ingvild ...................................Disclosed no confl ict of interest. HealthCare, BD Medical-Diabetes Care, Bristol-
Aust, Gabriela .....................................Disclosed no confl ict of interest. Myers Squibb Company, Cebix, Inc., Dexcom, Inc.,
Auster, Michael E. ...............................Disclosed no confl ict of interest. GlaxoSmithKline, Halozyme Therapeutics, Insulet
Autier, Philippe ....................................Disclosed no confl ict of interest. Corporation, LifeScan, Inc., LifeScan, Inc., Lilly
Autier, Valé rie .....................................Disclosed no confl ict of interest. Deutschland GmbH, MannKind Corporation, Medtronic,
Avery, Elizabeth ..................................Disclosed no confl ict of interest. Inc., Merck & Co., Inc., Novo Nordisk Inc., Orexigen
Avery, Robert L. ...................................Disclosed no confl ict of interest. Therapeutics, Inc., Sanofi U.S., Tandem Diabetes Care,
Avilés-Santa, Larissa ..........................Disclosed no confl ict of interest. Inc.; Speaker’s Bureau: Abbott, Novo Nordisk Inc.,
Avogaro, Angelo .................................Advisory Panel: Eli Lilly and Company, Sanofi Pasteur Sanofi U.S.
SA; Consultant: AstraZeneca/Bristol-Myers Squibb, Bain, James .........................................Disclosed no confl ict of interest.
Boehringer Ingelheim GmbH, Eli Lilly and Company, Bainbridge, Kathleen E. ......................Disclosed no confl ict of interest.
Janssen Pharmaceutical Companies of Johnson & Bajaj, Harpreet S. ................................Advisory Panel: AstraZeneca/Bristol-Myers Squibb,
Johnson, Novartis AG, Novo Nordisk Inc., Sanofi Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly
Pasteur SA, Servier, Takeda Pharmaceutical Company and Company, Janssen Pharmaceutical Companies of
Limited; Research Support: AstraZeneca/Bristol-Myers Johnson & Johnson, Merck & Co., Inc., Sanofi U.S.;
Squibb, Boehringer Ingelheim GmbH. Consultant: AstraZeneca/Bristol-Myers Squibb, Eli Lilly
Avotina, Gita .......................................Disclosed no confl ict of interest. and Company, Janssen Pharmaceutical Companies
Ayala, Jennifer E. ................................Disclosed no confl ict of interest. of Johnson & Johnson, Merck & Co., Inc.; Research
Ayala, Julio E. ......................................Disclosed no confl ict of interest. Support: AstraZeneca/Bristol-Myers Squibb, Eli Lilly
Aydin, Sinem ........................................Disclosed no confl ict of interest. and Company, Janssen Pharmaceutical Companies
Aye, Myint M. ......................................Disclosed no confl ict of interest. of Johnson & Johnson, Merck & Co., Inc., Novo
Aylor, Kevin W. ....................................Disclosed no confl ict of interest. Nordisk Inc., Pfi zer Inc., Regeneron Pharmaceuticals,
Ayumi, Hirose ......................................Disclosed no confl ict of interest. Inc., Sanofi U.S., Takeda Pharmaceutical Company
Azagury, Dan .......................................Disclosed no confl ict of interest. Limited; Speaker’s Bureau: Abbott Diabetes Care, Inc.,
Azar, Kristen M. ..................................Disclosed no confl ict of interest. AstraZeneca/Bristol-Myers Squibb, Bayer HealthCare,
A813
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
Boehringer Ingelheim Pharmaceuticals, Inc., Eli Lilly Barbee, Melanie ..................................Disclosed no confl ict of interest.
and Company, Janssen Pharmaceutical Companies of Barbosa, Margarida B. .......................Disclosed no confl ict of interest.
Johnson & Johnson, Merck & Co., Inc., Novo Nordisk Barbour, April M. .................................Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &
Inc., Sanofi U.S., Servier. Co., Inc.
Bajpeyi, Sudip ......................................Disclosed no confl ict of interest. Barbour, Linda A. .................................Disclosed no confl ict of interest.
Bakaj, Ivona .........................................Employee: Janssen Pharmaceutical Companies of Johnson Bar-Dayan, Yosefa ..............................Disclosed no confl ict of interest.
& Johnson. Bardenheier, Barbara ..........................Disclosed no confl ict of interest.
Baker, Chris ..........................................Disclosed no confl ict of interest. Barett, Eugene ....................................Disclosed no confl ict of interest.
Baker, Nathaniel .................................Disclosed no confl ict of interest. Bargellini, Irene ...................................Disclosed no confl ict of interest.
Baker, Scott .........................................Disclosed no confl ict of interest. Barger, Kelly ........................................Disclosed no confl ict of interest.
Bakillah, Ahmed ..................................Disclosed no confl ict of interest. Bargiota, Alexandra ............................Disclosed no confl ict of interest.
Bakker, Jessie P. ..................................Disclosed no confl ict of interest. Barker, Natalie ....................................Disclosed no confl ict of interest.
Bakris, George L. .................................Consultant: Abbvie, Bayer HealthCare, CVRx, Eli Lilly and Barker, Sarah .......................................Disclosed no confl ict of interest.
Company, GlaxoSmithKline, Janssen Pharmaceutical Barkhof, Frederik .................................Disclosed no confl ict of interest.
Companies of Johnson & Johnson, Medtronic, Inc., Barlow, Christopher K. ........................Disclosed no confl ict of interest.
Novartis Corporation; Research Support: Medtronic, Barlow, Susan .....................................Employee: Valeritas.
Inc., Relypsa, Takeda Pharmaceutical Company Limited. Barnea, Maayan ..................................Disclosed no confl ict of interest.
Bala, Malgorzata M. ...........................Disclosed no confl ict of interest. Barnes, Catherine S. ...........................Disclosed no confl ict of interest.
Balasubramanian, Kumar ...................Disclosed no confl ict of interest. Barnes, Tammy M. ..............................Disclosed no confl ict of interest.
Balasubramanyam, Muthusamy ........Disclosed no confl ict of interest. Barnett, Anthony H. ............................Advisory Panel: Boehringer Ingelheim GmbH, Bristol-
Balcázar-Nava, Patricia ......................Disclosed no confl ict of interest. Myers Squibb/AstraZeneca, Eli Lilly and Company,
Baldzizhar, Raman ...............................Disclosed no confl ict of interest. GlaxoSmithKline, Janssen Pharmaceutical Companies
E
R Balfour, David J. ..................................Disclosed no confl ict of interest. of Johnson & Johnson, Merck Sharp & Dohme, Novartis
U Balinski, Brenda ..................................Disclosed no confl ict of interest. Corporation, Novo Nordisk A/S, Roche Diagnostics,
S
Balis, Dainius .......................................Employee: Janssen Research & Development, LLC. Sanofi Pasteur SA, Takeda Pharmaceutical Company
O
L Balkau, Beverley .................................Disclosed no confl ict of interest. Limited; Speaker’s Bureau: Boehringer Ingelheim
C Balk-Møller, Emilie ..............................Disclosed no confl ict of interest. GmbH, Bristol-Myers Squibb/AstraZeneca, Eli Lilly and
S
I Ballance, Jim .......................................Employee: PhaseBio Pharmaceuticals, Inc.; Stock/ Company, GlaxoSmithKline, Janssen Pharmaceutical
D Shareholder: PhaseBio Pharmaceuticals, Inc. Companies of Johnson & Johnson, Merck Sharp &
R Ballantyne, Christie M. .......................Advisory Panel: Merck & Co., Inc., Pfi zer Inc.; Consultant: Dohme, Novartis Corporation, Novo Nordisk A/S, Roche
O
H Abbott, Amarin Pharma, Inc., Amgen Inc., AstraZeneca Diagnostics, Sanofi Pasteur SA, Takeda Pharmaceutical
T Pharmaceuticals LP, Cerenis, Esperion Therapeutics, Company Limited.
U Inc., Genentech, Inc., Genzyme Corporation, Kowa Bärnighausen, Till W. .........................Disclosed no confl ict of interest.
A Pharmaceuticals, Merck & Co., Inc., Novartis Baron, Alain .........................................Employee: Elcelyx Therapeutics, Inc.; Stock/Shareholder:
Corporation, Pfi zer Inc., Regeneron Pharmaceuticals, Elcelyx Therapeutics, Inc.
Inc., Sanofi -Synthelabo; Research Support: Abbott, Baron, Michelle ...................................Employee: Intarcia Therapeutics, Inc.
Amarin Pharma, Inc., American Heart Association, Barone, Bianca ....................................Disclosed no confl ict of interest.
Amgen Inc., Eli Lilly and Company, Esperion Barone, Francesca ..............................Disclosed no confl ict of interest.
Therapeutics, Inc., Genentech, Inc., GlaxoSmithKline, Barrat, Christophe ..............................Disclosed no confl ict of interest.
Merck & Co., Inc., National Institutes of Health, Barrett, Amy ........................................Disclosed no confl ict of interest.
Novartis Corporation, Pfi zer Inc., Regeneron Barrett, Eugene J. ...............................Disclosed no confl ict of interest.
Pharmaceuticals, Inc., Roche Diagnostics. Barrett, Terrance .................................Employee: Janssen Research & Development LLC.
Balliro, Courtney .................................Disclosed no confl ict of interest. Barrett, Yu Chen ..................................Employee: AstraZeneca Pharmaceuticals LP.
Balo, Andrew .......................................Employee: Dexcom, Inc. Barrett-Connor, Elizabeth ...................Disclosed no confl ict of interest.
Balogh, Elemer ....................................Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly Barrientos, Roberto ............................Disclosed no confl ict of interest.
and Company. Barron, John ........................................Consultant: Genentech, Inc.
Balogun, Williams ...............................Disclosed no confl ict of interest. Barros, Allan K. ...................................Disclosed no confl ict of interest.
Baltimore, David .................................Disclosed no confl ict of interest. Barrow, Breanne M. ............................Disclosed no confl ict of interest.
Baltzinger, Philippe .............................Disclosed no confl ict of interest. Barsnes, Harald ...................................Disclosed no confl ict of interest.
Baltzis, Dimitrios .................................Disclosed no confl ict of interest. Bartasis, Megan L. ..............................Disclosed no confl ict of interest.
Banba, Nobuyuki .................................Disclosed no confl ict of interest. Bartels, Dorothee ................................Employee: Boehringer Ingelheim GmbH.
Banchereau, Jacques .........................Disclosed no confl ict of interest. Barter, Philip ........................................Consultant: Resverlogix Corp.
Bandeira, Francisco ............................Disclosed no confl ict of interest. Bartlett, Katy .......................................Disclosed no confl ict of interest.
Bandeira, Leonardo .............................Disclosed no confl ict of interest. Bartman, Wojciech .............................Disclosed no confl ict of interest.
Bandholtz, Sebastian ..........................Disclosed no confl ict of interest. Bartoli, Manuela .................................Disclosed no confl ict of interest.
Banerjee, Mary Ann ............................Disclosed no confl ict of interest. Bartolomé, Alberto .............................Disclosed no confl ict of interest.
Banerjee, Rajarshi ...............................Disclosed no confl ict of interest. Bartykowszki, Andrea ........................Disclosed no confl ict of interest.
Bang, Claudia ......................................Disclosed no confl ict of interest. Bartz, Sara ...........................................Disclosed no confl ict of interest.
Banks, Alexander ................................Disclosed no confl ict of interest. Barzi, Federica .....................................Disclosed no confl ict of interest.
Banks, Jaminelli L. ..............................Disclosed no confl ict of interest. Barzilai, Nir ..........................................Disclosed no confl ict of interest.
Bansal, Anubhuti .................................Employee: Medtronic, Inc. Basani, Samata ...................................Disclosed no confl ict of interest.
Bantle, Anne ........................................Disclosed no confl ict of interest. Basaraba, Randall J. ...........................Disclosed no confl ict of interest.
Banton, Tom .........................................Research Support: LifeScan, Inc. Basch, Peter ........................................Disclosed no confl ict of interest.
Bantwal, Ganapathi M. ......................Advisory Panel: Novo Nordisk Inc. Basile, Giorgio .....................................Disclosed no confl ict of interest.
Banu, Isabela .......................................Disclosed no confl ict of interest. Basile, Kevin J. ....................................Disclosed no confl ict of interest.
Bao, Haikun .........................................Disclosed no confl ict of interest. Basina, Marina ....................................Disclosed no confl ict of interest.
Bao, Rudi ..............................................Disclosed no confl ict of interest. Bassi, Roberto .....................................Disclosed no confl ict of interest.
Bao, Wei ..............................................Disclosed no confl ict of interest. Basta, Giuseppe ..................................Disclosed no confl ict of interest.
Bao, Yuqian ..........................................Disclosed no confl ict of interest. Bastean, Brian .....................................Employee: Janssen Pharmaceutical Companies of Johnson
Baptiste, Amandine ............................Disclosed no confl ict of interest. & Johnson (Spouse/Partner), Johnson & Johnson; Stock/
Baqar, Sara ..........................................Disclosed no confl ict of interest. Shareholder: Johnson & Johnson, Johnson & Johnson
Bar Ilan, Ahuva ....................................Disclosed no confl ict of interest. (Spouse/Partner).
Bar, Merav ...........................................Disclosed no confl ict of interest. Bastie, Claire C. ...................................Disclosed no confl ict of interest.
Barabanov, Valeriy M. ........................Disclosed no confl ict of interest. Bastyr III, Edward J. ...........................Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
Baragaba, Basim .................................Disclosed no confl ict of interest. and Company.
Barak-Corren, Yuval ............................Disclosed no confl ict of interest. Basu, Ananda ......................................Disclosed no confl ict of interest.
Baranov, Oleg ......................................Disclosed no confl ict of interest. Basu, Arpita .........................................Disclosed no confl ict of interest.
Barash, Hilla ........................................Disclosed no confl ict of interest. Basu, Rita ............................................Research Support: Dexcom, Inc.
Barataud, Aude ...................................Disclosed no confl ict of interest. Basu, Sanjay ........................................Disclosed no confl ict of interest.
Barb, Diana ..........................................Disclosed no confl ict of interest. Batch, Bryan ........................................Disclosed no confl ict of interest.
Barbaresso, Rebecca ..........................Disclosed no confl ict of interest. Batchu, Sri N. ......................................Disclosed no confl ict of interest.
Barbas, Coral .......................................Disclosed no confl ict of interest. Batista, Thiago ....................................Disclosed no confl ict of interest.
A814
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
Batra, Manav .......................................Disclosed no confl ict of interest. Bellin, Melena D. .................................Consultant: Viacyte; Research Support: Dompe
Batra, Meenakshi ...............................Employee: Voxiva, Inc. Pharmaceuticals, Medtronic, Inc., Merck & Co., Inc.
Battezzati, Alberto ..............................Disclosed no confl ict of interest. Bello, Gabriela B. ................................Disclosed no confl ict of interest.
Bauduceau, Bernard ...........................Disclosed no confl ict of interest. Belokovskaya, Regina .........................Disclosed no confl ict of interest.
Bauer, John A. .....................................Disclosed no confl ict of interest. Below, Jennifer E. ...............................Disclosed no confl ict of interest.
Bauer, Tim A. .......................................Disclosed no confl ict of interest. Belton, Anne ........................................Advisory Panel: Abbot, Boehringer Ingelheim, Sanofi on
Bauer, Witold ......................................Disclosed no confl ict of interest. programs for the International Diabetes Federation;
Baugh, Christopher .............................Disclosed no confl ict of interest. Consultant: Lifescan Canada.
Baum, Diana ........................................Disclosed no confl ict of interest. Ben Nasr, Moufi da ..............................Disclosed no confl ict of interest.
Baum, Ellen Z. ......................................Disclosed no confl ict of interest. Bena, James ........................................Disclosed no confl ict of interest.
Baumann, Matthias ............................Employee: NOXXON Pharma AG. Benbenek-Klupa, Teresa ....................Disclosed no confl ict of interest.
Baumann, Petra M. .............................Disclosed no confl ict of interest. Bendeck, Michelle ..............................Disclosed no confl ict of interest.
Baumgartner, Amy ..............................Disclosed no confl ict of interest. Bender, Corey ......................................Disclosed no confl ict of interest.
Bautista, Kimberly A. ..........................Disclosed no confl ict of interest. Bendre, Rohan .....................................Disclosed no confl ict of interest.
Baverel, Gabriel ..................................Stock/Shareholder: Metabolys Inc. Benes, Marek ......................................Disclosed no confl ict of interest.
Bavinger, Clay ......................................Disclosed no confl ict of interest. Benetti, Alberto ..................................Disclosed no confl ict of interest.
Baxter, Judith ......................................Disclosed no confl ict of interest. Benias, Petros .....................................Disclosed no confl ict of interest.
Baxter, Mark A. ...................................Disclosed no confl ict of interest. Benitez, Amanda .................................Research Support: National Institutes of Health.
Bayer, Allison L. ...................................Disclosed no confl ict of interest. Beniwal, Sanjay ..................................Disclosed no confl ict of interest.
Baz, Baz ...............................................Disclosed no confl ict of interest. Benjamin, Santhosh J. ........................Disclosed no confl ict of interest.
Bazinet, Richard P. ..............................Disclosed no confl ict of interest. Ben-Mayor, Ram .................................Disclosed no confl ict of interest.
Bazyka, Dmitrii ....................................Disclosed no confl ict of interest. Bennakhi, Abdullah .............................Disclosed no confl ict of interest.
E
Beal, John ............................................Disclosed no confl ict of interest. Bennedetti, Luiza ................................Disclosed no confl ict of interest. R
Beall, Craig ..........................................Disclosed no confl ict of interest. Bennet, Michael ..................................Disclosed no confl ict of interest. U
S
Beals, John M. ....................................Board Member: Rose Human Institute of Technology, Bennett, Amanda J. ............................Disclosed no confl ict of interest.
O
Biology and Biomedical Engineering; Employee: Eli Lilly Bennett, Heather ................................Disclosed no confl ict of interest. L
and Company; Stock/Shareholder: Eli Lilly and Company, Bennett, Peter H. ................................Disclosed no confl ict of interest. C
S
Eli Lilly and Company (Spouse/Partner). Benninger, Richard K. .........................Disclosed no confl ict of interest. I
Beamish, Christine A. .........................Disclosed no confl ict of interest. Bensenor, Isabela M. ..........................Disclosed no confl ict of interest. D
Bean, Eric .............................................Employee: DiabetOmics, Inc. Bentley, Amy .......................................Disclosed no confl ict of interest. R
O
Beaton, Joan .......................................Disclosed no confl ict of interest. Bentley-Lewis, Rhonda ......................Consultant: Sanofi U.S.; Research Support: Novartis H
Beauharnais, Catherine C. .................Disclosed no confl ict of interest. Pharmaceuticals Corporation (Spouse/Partner), Sanofi T
Beauregard, Natalie ...........................Disclosed no confl ict of interest. U.S., Sanofi U.S. (Spouse/Partner). U
Bebakar, Wan Mohamad W. ..............Advisory Panel: Novo Nordisk A/S. Bequette, B. Wayne ............................Consultant: Becton, Dickinson and Company. A
Bebu, Ionut ..........................................Disclosed no confl ict of interest. Bera, Amal Kanti K. .............................Disclosed no confl ict of interest.
Beccaria, Andrea ................................Disclosed no confl ict of interest. Berard, Lori ..........................................Advisory Panel: Abbott, AstraZeneca, Bayer, BD, Eli Lilly
Bechaz, Marisa ...................................Disclosed no confl ict of interest. Canada, Janssen, Lifescan, Merck, Novo Nordisk,
Beck, Hans C. ......................................Disclosed no confl ict of interest. Sanofi ; Consultant: Abbott, AstraZeneca, Bayer, BD, Eli
Beck, Joni K. ........................................Disclosed no confl ict of interest. Lilly Canada, Janssen, Lifescan, Merck, Novo Nordisk,
Beck, Roy W. .......................................Disclosed no confl ict of interest. Sanofi ; Speaker’s Bureau: Abbott, AstraZeneca, Bayer,
Beck, Stephan .....................................Disclosed no confl ict of interest. BD, Eli Lilly Canada, Janssen, Lifescan, Merck, Novo
Becker, Ann .........................................Disclosed no confl ict of interest. Nordisk, Sanofi .
Becker, Dorothy ...................................Disclosed no confl ict of interest. Berends, Frits ......................................Disclosed no confl ict of interest.
Becker, Reinhard .................................Employee: Sanofi . Berg, Cynthia A. ..................................Research Support: National Institute of Diabetes and
Becker, Robert .....................................Disclosed no confl ict of interest. Digestive and Kidney Diseases.
Beckers, Johannes ..............................Disclosed no confl ict of interest. Bergamini, Corinna .............................Disclosed no confl ict of interest.
Beckles, Gloria L. ................................Disclosed no confl ict of interest. Bergenheim, Klas ................................Employee: AstraZeneca Pharmaceuticals LP; Stock/
Beck-Nielsen, Henning .......................Other Relationship: Novo Nordisk A/S; Research Support: Shareholder: AstraZeneca Pharmaceuticals LP.
Novo Nordisk A/S. Bergenstal, Richard M. .......................Advisory Panel: Abbott Diabetes Care, Inc., AstraZeneca/
Beddow, Sara A. .................................Disclosed no confl ict of interest. Bristol-Myers Squibb, Bayer HealthCare, Boehringer
Bedini, Jose Luis .................................Disclosed no confl ict of interest. Ingelheim GmbH, Calibra, Eli Lilly and Company,
Bednarek, Maria .................................Employee: MedImmune, Inc. Halozyme Therapeutics, Hygieia, Johnson & Johnson,
Bednarik, Petr ......................................Disclosed no confl ict of interest. Medtronic, Inc., Novo Nordisk Inc., Roche USA,
Bedogni, Giorgio ..................................Disclosed no confl ict of interest. Sanofi U.S., Takeda Pharmaceuticals U.S.A., Inc., The
Bee, Yong M. .......................................Disclosed no confl ict of interest. Leona M. and Harry B. Helmsley Charitable Trust,
Beegle, Richard ...................................Disclosed no confl ict of interest. Valeritas; Research Support: Abbott Diabetes Care, Inc.,
Beeney, Linda J. ..................................Disclosed no confl ict of interest. AstraZeneca/Bristol-Myers Squibb, Bayer HealthCare,
Beer, Zivan ...........................................Disclosed no confl ict of interest. Becton, Dickinson and Company, Boehringer Ingelheim
Beggio, Valentina ................................Disclosed no confl ict of interest. GmbH, Calibra, Eli Lilly and Company, Halozyme
Begovatz, Paul .....................................Disclosed no confl ict of interest. Therapeutics, Hygieia, Johnson & Johnson, Medtronic,
Begtrup, Kamilla .................................Employee: Novo Nordisk A/S; Stock/Shareholder: Novo Inc., Merck & Co., Inc., National Institutes of Health,
Nordisk A/S. Novo Nordisk Inc., ResMed, Roche USA, Sanofi U.S.,
Behar, Mourad .....................................Employee: Sanofi France. Takeda Pharmaceuticals U.S.A., Inc., The Leona M. and
Behbehani, Kazem ..............................Disclosed no confl ict of interest. Harry B. Helmsley Charitable Trust.
Behr-Roussel, Delphine ......................Research Support: Boehringer Ingelheim Pharmaceuticals, Berger, Andrea L. ................................Disclosed no confl ict of interest.
Inc. Berger-Marshall, Michelle .................Disclosed no confl ict of interest.
Beilman, Gregory J. ............................Disclosed no confl ict of interest. Bergeron, Valerie ................................Disclosed no confl ict of interest.
Belardinelli, Luiz ..................................Employee: Gilead; Stock/Shareholder: Gilead. Berggren, Erica K. ...............................Disclosed no confl ict of interest.
Belfort-DeAguiar, Renata ...................Disclosed no confl ict of interest. Berggren, Johan ..................................Disclosed no confl ict of interest.
Beli, Eleni .............................................Disclosed no confl ict of interest. Berggren, Per-Olof ..............................Disclosed no confl ict of interest.
Belichenko, Pavel ................................Disclosed no confl ict of interest. Bergh, Eric ...........................................Disclosed no confl ict of interest.
Belinova, Lenka ...................................Disclosed no confl ict of interest. Bergheim, Ina ......................................Disclosed no confl ict of interest.
Bell, Douglas .......................................Disclosed no confl ict of interest. Bergholt, Thomas ................................Disclosed no confl ict of interest.
Bell, Graeme I. .....................................Disclosed no confl ict of interest. Bergis-Jurgan, Nikola .........................Research Support: Berlin-Chemie AG; Speaker’s Bureau:
Bell, Kelly .............................................Employee: AstraZeneca Pharmaceuticals LP. Berlin-Chemie AG.
Bell, Kirstine J. ....................................Disclosed no confl ict of interest. Berglund, Eric ......................................Disclosed no confl ict of interest.
Bell, Ronny A. ......................................Disclosed no confl ict of interest. Bergman, Arthur .................................Disclosed no confl ict of interest.
Bellamy, David J. .................................Disclosed no confl ict of interest. Bergman, Bryan C. ..............................Research Support: Eli Lilly and Company.
Bellan, Mattia .....................................Disclosed no confl ict of interest. Bergman, Richard N. ...........................Consultant: Amylin Pharmaceuticals, LLC., Ingredion, Novo
Bellia, Alfonso .....................................Disclosed no confl ict of interest. Nordisk Inc.; Speaker’s Bureau: Merck-Schering Plough;
Bellido, Diego ......................................Disclosed no confl ict of interest. Stock/Shareholder: Tethys Bioscience.
Bellili-Muñoz, Naïma ..........................Disclosed no confl ict of interest. Bergmann, Karin .................................Employee: Sanofi ; Stock/Shareholder: Sanofi .
A815
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
Bergmeier, Stephen ............................Disclosed no confl ict of interest. Population Health Research Institute, Unfunded
Bergouignan, Audrey ..........................Disclosed no confl ict of interest. Research: FlowCo, PLx Pharma, Takeda.; Research
Berkowitz, Seth A. ..............................Disclosed no confl ict of interest. Support: Amarin, AstraZeneca, Bristol-Myers
Berkseth, Kathryn E. ...........................Disclosed no confl ict of interest. Squibb, Eisai, Ethicon, Forest Laboratories, Ischemix,
Berlanga Escalera, Eugenio ...............Disclosed no confl ict of interest. Medtronic, Pfizer, Roche, Sanofi Aventis, The
Berlie, Helen ........................................Disclosed no confl ict of interest. Medicines Company.
Berman, Dora M. .................................Disclosed no confl ict of interest. Bhattacharjee, Sandipan ....................Research Support: Sanofi U.S.
Berman, Lance ....................................Employee: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. Bhattacharya, Rituparna ....................Research Support: Sanofi U.S.
Bernabé, Jacques ...............................Research Support: Boehringer Ingelheim Pharmaceuticals, Bhattacharya, Sudipta .......................Employee: AstraZeneca Pharmaceuticals LP.
Inc. Bhatwadekar, Ashay D. ......................Disclosed no confl ict of interest.
Bernal-Mizrachi, Ernesto ...................Disclosed no confl ict of interest. Bhoi, Bibhuti ........................................Employee: Cadila Healthcare Limited.
Bernheim, Susannah M. .....................Disclosed no confl ict of interest. Bi, Yan ..................................................Disclosed no confl ict of interest.
Bernjak, Alan .......................................Disclosed no confl ict of interest. Biaggioni, Italo ....................................Disclosed no confl ict of interest.
Bernlohr, David A. ...............................Disclosed no confl ict of interest. Bian, Hua .............................................Disclosed no confl ict of interest.
Berrah, Abdelkrim ...............................Advisory Panel: AstraZeneca Pharmaceuticals LP, Bayer Bianchi, Cristina ..................................Disclosed no confl ict of interest.
HealthCare, Merck Sharp & Dohme, Novartis AG, Bider, Zoe .............................................Disclosed no confl ict of interest.
Novo Nordisk A/S, Pfi zer Inc., Sanofi U.S.; Consultant: Bielicki, John .......................................Advisory Panel: Artery Therapeutics; Research Support:
Saidal, Sanofi U.S.; Speaker’s Bureau: AstraZeneca Artery Therapeutics.
Pharmaceuticals LP, HIKMA, Merck Serono, Novartis Biermans, Marion C. ...........................Disclosed no confl ict of interest.
AG, Novo Nordisk A/S, Saidal, Sanofi U.S. Biernacki, Diane ..................................Disclosed no confl ict of interest.
Berria, Rachele ....................................Employee: Sanofi ; Stock/Shareholder: Sanofi . Bierwagen, Alessandra ......................Disclosed no confl ict of interest.
Berry, Barbara .....................................Disclosed no confl ict of interest. Biester, Torben ....................................Disclosed no confl ict of interest.
E
R Berry, Pam C. .......................................Employee: GlaxoSmithKline; Stock/Shareholder: Bieszk, Nella ........................................Employee: Sanofi U.S.
U GlaxoSmithKline. Bigger-Allen, Alexander A. .................Disclosed no confl ict of interest.
S
Berry, Rodney ......................................Disclosed no confl ict of interest. Biggio, Joseph R. ................................Disclosed no confl ict of interest.
O
L Berryman, Darlene E. ..........................Disclosed no confl ict of interest. Biggs, Mary Lou ..................................Disclosed no confl ict of interest.
C Bertola, Susana Carolina ....................Disclosed no confl ict of interest. Bijos, Pawel .........................................Disclosed no confl ict of interest.
S
I Bertoli, Simona ....................................Disclosed no confl ict of interest. Bilic Curcic, Ines ..................................Disclosed no confl ict of interest.
D Bertolotto, Alessandra .......................Disclosed no confl ict of interest. Bilic, Jelena .........................................Disclosed no confl ict of interest.
R Bertoni, Alain ......................................Disclosed no confl ict of interest. Bilir, Sara P. ..........................................Consultant: Takeda Pharmaceutical Company Limited.
O
H Bertran, Elizabeth A. ...........................Disclosed no confl ict of interest. Billestrup, Nils .....................................Disclosed no confl ict of interest.
T Bertrand, Anne-Marie ........................Disclosed no confl ict of interest. Billger, Martin .....................................Employee: AstraZeneca Pharmaceuticals LP; Stock/
U Bertrand, Gyslaine ..............................Disclosed no confl ict of interest. Shareholder: AstraZeneca Pharmaceuticals LP.
A Besenböck, Carolin .............................Disclosed no confl ict of interest. Billheimer, Dean ..................................Disclosed no confl ict of interest.
Best, James D. ....................................Research Support: Roche Diagnostics, Roche Diagnostics Bilodeau, Jean-François .....................Disclosed no confl ict of interest.
(Spouse/Partner), sanofi , sanofi (Spouse/Partner). Bilous, Mary ........................................Disclosed no confl ict of interest.
Bethin, Kathleen E. .............................Disclosed no confl ict of interest. Bilous, Rudy .........................................Disclosed no confl ict of interest.
Betsholtz, Christer ..............................Disclosed no confl ict of interest. Bimson, Brianne ..................................Disclosed no confl ict of interest.
Beverly, Elizabeth A. ...........................Disclosed no confl ict of interest. Bin, Huang ...........................................Disclosed no confl ict of interest.
Bevier, Wendy C. .................................Disclosed no confl ict of interest. Bing, Chen ............................................Disclosed no confl ict of interest.
Bevilacqua, Sarah C. ...........................Disclosed no confl ict of interest. Bing, Sun ..............................................Disclosed no confl ict of interest.
Beyan, Huriya ......................................Disclosed no confl ict of interest. Binikos, Isidoros ..................................Disclosed no confl ict of interest.
Beyazyildiz, Emrullah ..........................Disclosed no confl ict of interest. Binkley, Philip ......................................Disclosed no confl ict of interest.
Beyersmann, Jan ................................Disclosed no confl ict of interest. Binko, Deborah ....................................Disclosed no confl ict of interest.
Beysen, Carine ....................................Employee: KineMed, Inc. Binstock, Anna ....................................Disclosed no confl ict of interest.
Bezwada, Padma .................................Employee: XOMA Corporation. Biondi, Giuseppina ..............................Disclosed no confl ict of interest.
Bgatova, Natalia P. .............................Disclosed no confl ict of interest. Birdsey, Nicholas ................................Disclosed no confl ict of interest.
Bhagroo, Nicholas ...............................Disclosed no confl ict of interest. Birk, Jesper B. .....................................Disclosed no confl ict of interest.
Bhan, Arti ............................................Disclosed no confl ict of interest. Birkeland, Kåre I. .................................Disclosed no confl ict of interest.
Bhandari, Amit ....................................Employee: Boehringer Ingelheim Pharmaceuticals Inc. Birkenfeld, Andreas L. ........................Disclosed no confl ict of interest.
Bhandari, Sudhir ..................................Disclosed no confl ict of interest. Birnbaum, Howard G. .........................Research Support: Eli Lilly and Company.
Bhanot, Sanjay ....................................Employee: Isis Pharmaceuticals, Inc. Bisceglia, Luigi ....................................Disclosed no confl ict of interest.
Bhargava, Anuj ....................................Advisory Panel: Abbott, AstraZeneca; Research Support: Bissonnette, Simon .............................Disclosed no confl ict of interest.
AstraZeneca, Bristol-Myers Squibb Company, Bittner, Stefanie ..................................Disclosed no confl ict of interest.
Duke Clinical Research Inst, Eli Lilly and Company, Bitton, Gabriel .....................................Employee: Insuline Medical Ltd.
GlaxoSmithKline, Halozyme Therapeutics, JAEB, Bjerre Knudsen, Lotte .........................Employee: Novo Nordisk A/S; Stock/Shareholder: Novo
Janssen, Medtronic, Mylan, Novo Nordisk, Orexigen Nordisk A/S.
Therapeutics, Inc., Sanofi , Univ. of Oxford; Speaker’s Bjoernshave, Ann ................................Disclosed no confl ict of interest.
Bureau: AstraZeneca, Janssen, Sanofi . Björk, Magnus B. .................................Disclosed no confl ict of interest.
Bharucha, Adil E. .................................Disclosed no confl ict of interest. Bjørkhaug Gundersen, Lise ................Disclosed no confl ict of interest.
Bhat, Sathesh ......................................Disclosed no confl ict of interest. Bjørkhaug, Lise ....................................Disclosed no confl ict of interest.
Bhatt, Deepak ....................................Advisory Panel: Cardax, Elsevier Practice Update Björkman, Anders ...............................Disclosed no confl ict of interest.
Cardiology, Medscape Cardiology, Regado Bjørling-Poulsen, Marina ....................Disclosed no confl ict of interest.
Biosciences; Board Member: Boston VA Research Bjørlykke, Yngvild ...............................Disclosed no confl ict of interest.
Institute, Society of Cardiovascular Patient Bjørner, Jakob B. .................................Employee: Optum.
Care;Chair: American Heart Association Get With Bjornstad, Petter .................................Disclosed no confl ict of interest.
The Guidelines Steering Committee; Consultant: Blaak, Ellen ..........................................Disclosed no confl ict of interest.
American College of Cardiology (Senior Associate Black, Mary Helen ...............................Disclosed no confl ict of interest.
Editor, Clinical Trials and News, ACC.org), Belvoir Blackberry, Irene .................................Research Support: Roche Diagnostics, sanofi .
Publications (Editor in Chief, Harvard Heart Letter), Blackburn, Brian K. .............................Disclosed no confl ict of interest.
Duke Clinical Research Institute (clinical trial Blackburn, Mary Clare ........................Disclosed no confl ict of interest.
steering committees), Harvard Clinical Research Blackshear, Chad .................................Disclosed no confl ict of interest.
Institute (clinical trial steering committee), HMP Blagajcevic, Alen ................................Disclosed no confl ict of interest.
Communications (Editor in Chief, Journal of Invasive Blair, A.B. .............................................Disclosed no confl ict of interest.
Cardiology), Journal of the American College Blandino-Rosano, Manuel ..................Disclosed no confl ict of interest.
of Cardiology (Associate Editor; Section Editor, Blaner, William S. ...............................Disclosed no confl ict of interest.
Pharmacology), Population Health Research Institute Blangero, John ....................................Disclosed no confl ict of interest.
(clinical trial steering committee), Slack Publications Blankert, Femke M. .............................Disclosed no confl ict of interest.
(Chief Medical Editor, Cardiology Today’s Blankfard, Martin ................................Disclosed no confl ict of interest.
Intervention), WebMD (CME steering committees); Blaslov, Kristina ..................................Disclosed no confl ict of interest.
Other Relationship: Duke Clinical Research Institute, Blaszkiewicz, Magdalena ...................Disclosed no confl ict of interest.
Harvard Clinical Research Institute, Mayo Clinic, Blaychfeld– Magnazi, Moran ............Disclosed no confl ict of interest.
A816
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
Blecker, Saul ........................................Disclosed no confl ict of interest. Bolli, Geremia B. ..................................Advisory Panel: Sanofi ; Consultant: Novartis; Speaker’s
Blevins, Thomas ..................................Advisory Panel: Eli Lilly and Company, Sanofi U.S.; Bureau: Eli Lilly.
Consultant: Eli Lilly and Company; Research Support: Eli Bolo, Nicolas R. ...................................Disclosed no confl ict of interest.
Lilly and Company, Janssen Pharmaceutical Companies Bolz, Steffen T. ....................................Disclosed no confl ict of interest.
of Johnson & Johnson, Merck & Co., Inc., Mylan, Bolze, Sebastien .................................Disclosed no confl ict of interest.
Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau: Bombo, Renata ....................................Disclosed no confl ict of interest.
AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Bompada, Pradeep ..............................Disclosed no confl ict of interest.
Pharmaceuticals, Inc., Eli Lilly and Company, Merck & Bonaca, Marc ......................................Consultant: AstraZeneca Pharmaceuticals LP, Bayer
Co., Inc., Sanofi U.S. HealthCare, Merck & Co., Inc., Roche Diagnostics;
Blicher, Marie K. ..................................Disclosed no confl ict of interest. Research Support: AstraZeneca/Bristol-Myers Squibb,
Block, Clifford H. .................................Other Relationship: NutritionQuest co-owner. Bayer HealthCare, Daiichi-Sankyo Co., Ltd., Eisai Co.,
Block, Gladys .......................................Other Relationship: NutritionQuest. Ltd., Gilead, GlaxoSmithKline, Johnson & Johnson,
Block, Torin J. ......................................Other Relationship: co-owner, NutritionQuest. Merck & Co., Inc.
Blom, Dirk ............................................Consultant: Aegerion Pharmaceuticals, Inc., Merck Sharp & Bonadonna, Riccardo C. .....................Disclosed no confl ict of interest.
Dohme, Sanofi Pasteur SA; Other Relationship: Aegerion Bonafede, Machaon ...........................Consultant: Truven Health Analytics Inc.
Pharmaceuticals, Inc., Amgen Inc., AstraZeneca Bonami, Rachel H. ...............................Disclosed no confl ict of interest.
Pharmaceuticals LP, Merck Sharp & Dohme, Bonapace, Stefano .............................Disclosed no confl ict of interest.
PharmaDynamics, Sanofi Pasteur SA. Bonàs, Sílvia ........................................Disclosed no confl ict of interest.
Blonde, Lawrence ...............................Consultant: AstraZeneca Pharmaceuticals LP, Bondor, Cosmina I. ..............................Consultant: Worwag Pharma.
GlaxoSmithKline, Janssen Pharmaceutical Companies Bone, Derek B. .....................................Disclosed no confl ict of interest.
of Johnson & Johnson, Merck & Co., Inc., Novo Bonfadini, Silvia ..................................Disclosed no confl ict of interest.
Nordisk A/S, Quest Diagnostics, Sanofi -aventis; Bonfi glio, Amedeo ...............................Disclosed no confl ict of interest.
E
Research Support: Eli Lilly and Company, Novo Nordisk Bongaerts, Brenda W.C. .....................Disclosed no confl ict of interest. R
A/S, Sanofi -aventis; Speaker’s Bureau: AstraZeneca Bonifacio, Ezio .....................................Disclosed no confl ict of interest. U
S
Pharmaceuticals LP, Janssen Pharmaceutical Bonilla, Cindy D. ..................................Disclosed no confl ict of interest.
O
Companies of Johnson & Johnson, Merck & Co., Inc., Bonine, Nicole .....................................Other Relationship: employee of HealthCore, Inc., L
Novo Nordisk A/S, Sanofi -aventis. contracted on behalf of Sanofi US, Inc. C
S
Blondeau, Bertrand .............................Disclosed no confl ict of interest. Boniol, Mathieu ...................................Disclosed no confl ict of interest. I
Bloom, David E. ...................................Disclosed no confl ict of interest. Böni-Schnetzler, Marianne ................Disclosed no confl ict of interest. D
Bloomgarden, Noah ............................Disclosed no confl ict of interest. Bonnefond, Amélie .............................Disclosed no confl ict of interest. R
O
Blouin, Jean-Louis ..............................Disclosed no confl ict of interest. Bonner-Weir, Susan ............................Disclosed no confl ict of interest. H
Blüher, Matthias .................................Advisory Panel: AstraZeneca Pharmaceuticals LP, Bonnes, Harmony ................................Disclosed no confl ict of interest. T
Boehringer Ingelheim GmbH, Eli Lilly and Company, Bonnici, François .................................Research Support: AstraZeneca Pharmaceuticals LP, Novo U
Novartis Pharma GmbH, Novo Nordisk A/S, Sanofi U.S.; Nordisk Inc.; Speaker’s Bureau: Sanofi U.S. A
Consultant: AstraZeneca Pharmaceuticals LP, Berlin- Bonomi, Lara .......................................Disclosed no confl ict of interest.
Chemie AG, Boehringer Ingelheim GmbH, Eli Lilly and Bonora, Enzo ........................................Disclosed no confl ict of interest.
Company, Novartis Pharma GmbH, Novo Nordisk A/S, Boodhansingh, Kara E. ........................Disclosed no confl ict of interest.
Sanofi U.S.; Research Support: ALTANA, Boehringer Boonin, Alan ........................................Disclosed no confl ict of interest.
Ingelheim GmbH, Riemser; Speaker’s Bureau: Booth, Gillian L. ...................................Disclosed no confl ict of interest.
AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim Booth, Robby .......................................Employee: Glytec.
GmbH, Eli Lilly and Company, Johnson & Johnson, Borch-Johnsen, Knut ..........................Stock/Shareholder: Novo Nordisk A/S.
Novartis Pharma GmbH, Novo Nordisk A/S, Pfi zer Inc., Borck, Anja ..........................................Employee: Sanofi .
Riemser, Sanofi U.S. Bordier, Lyse ........................................Disclosed no confl ict of interest.
Bluhmki, Tobias ...................................Disclosed no confl ict of interest. Bordin, Silvana ....................................Disclosed no confl ict of interest.
Blum, Janice ........................................Disclosed no confl ict of interest. Borg, Danielle J. ..................................Disclosed no confl ict of interest.
Blumer, Ian ...........................................Advisory Panel: Animas Corporation, Bayer HealthCare, Borges-Yañez, Socorro Aida ..............Disclosed no confl ict of interest.
BD Medical-Diabetes Care, Bristol-Myers Squibb/ Borgman, Sarah K. ..............................Consultant: Eli Lilly and Company.
AstraZeneca, Eli Lilly and Company, Janssen Boright, Andrew P. ..............................Disclosed no confl ict of interest.
Pharmaceutical Companies of Johnson & Johnson, Boron-Brenner, Daniel ........................Disclosed no confl ict of interest.
Medtronic, Inc., Merck & Co., Inc., Novo Nordisk Inc., Borowiak, Malgorzata ........................Disclosed no confl ict of interest.
Roche USA, Sanofi U.S. Borowiec, Maciej ................................Disclosed no confl ict of interest.
Boa, Beatriz C. .....................................Disclosed no confl ict of interest. Børsheim, Elisabet ..............................Disclosed no confl ict of interest.
Bobelu, J. .............................................Disclosed no confl ict of interest. Boscari, Federico ................................Speaker’s Bureau: Roche Diagnostics.
Bobo, Janet K. .....................................Disclosed no confl ict of interest. Bosch, Tyler .........................................Disclosed no confl ict of interest.
Boccio, Mindy ......................................Disclosed no confl ict of interest. Boscheinen, Oliver ..............................Disclosed no confl ict of interest.
Bode, Bruce W. ....................................Advisory Panel: Janssen, Novo Nordisk A/S, Sanofi U.S.; Boschmann, Michael ..........................Disclosed no confl ict of interest.
Consultant: Janssen, Novo Nordisk A/S, Sanofi Bose, Tanushree ..................................Employee: Metagenics, Inc.
U.S.; Research Support: Eli Lilly and Company, Boselli, Linda .......................................Disclosed no confl ict of interest.
GlaxoSmithKline, Johnson & Johnson, Merck & Co., Bosnic, Nevzeta .................................Employee: IMS Brogan; Research Support:
Inc., Novo Nordisk A/S, Sanofi U.S.; Speaker’s Bureau: GlaxoSmithKline.
AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Bossowski, Artur ................................Disclosed no confl ict of interest.
GlaxoSmithKline, Merck & Co., Inc., Novo Nordisk A/S, Bostick, Brian P. ..................................Disclosed no confl ict of interest.
Sanofi U.S. Boström, Pontus ..................................Disclosed no confl ict of interest.
Bodegard, Johan .................................Employee: AstraZeneca Pharmaceuticals LP. Bosworth, Hayden B. ..........................Disclosed no confl ict of interest.
Boegelund, Mette ...............................Consultant: Novo Nordisk A/S. Bota, Maria .........................................Disclosed no confl ict of interest.
Boehm, Bernhard ................................Disclosed no confl ict of interest. Bøtker, Hans Erik .................................Disclosed no confl ict of interest.
Boehnke, Michael ...............................Disclosed no confl ict of interest. Botros, Fady T. .....................................Employee: Eli Lilly and Company, Eli Lilly and Company
Boerwinkle, Eric ..................................Disclosed no confl ict of interest. (Spouse/Partner); Stock/Shareholder: Eli Lilly and
Bogardus, Clifton ................................Disclosed no confl ict of interest. Company, Eli Lilly and Company (Spouse/Partner).
Bogdanov, Patricia ..............................Disclosed no confl ict of interest. Bou, Ricardo ........................................Disclosed no confl ict of interest.
Boggi, Ugo ...........................................Disclosed no confl ict of interest. Boucai, Laura .......................................Disclosed no confl ict of interest.
Boh, Eileen T. .......................................Disclosed no confl ict of interest. Bouchard, Jo .......................................Disclosed no confl ict of interest.
Bohnett, Lucas ....................................Employee: Dexcom, Inc. Bouchard, Jonathan ...........................Employee: Novo Nordisk Inc.
Boisen, Ida ...........................................Disclosed no confl ict of interest. Boucher, Jeremie ................................Disclosed no confl ict of interest.
Bojsen-Møller, Kirstine N. ..................Disclosed no confl ict of interest. Bouchi, Ryotaro ...................................Disclosed no confl ict of interest.
Bokvist, Krister ...................................Employee: Eli Lilly and Company. Bouchier-Hayes, David .......................Disclosed no confl ict of interest.
Bolanis, Esther M. ...............................Disclosed no confl ict of interest. Boudaba, Nadia ...................................Disclosed no confl ict of interest.
Bolen, Shari .........................................Disclosed no confl ict of interest. Boudina, Sihem ...................................Disclosed no confl ict of interest.
Bolge, Susan C. ...................................Employee: Janssen Pharmaceutical Companies of Johnson Boudou, Philippe .................................Disclosed no confl ict of interest.
& Johnson; Stock/Shareholder: Johnson & Johnson. Bouenizabila, Evariste ........................Disclosed no confl ict of interest.
Bolick, Natasha G. ..............................Employee: Becton, Dickinson and Company; Stock/ Boulet, Genevieve ...............................Disclosed no confl ict of interest.
Shareholder: Becton, Dickinson and Company. Boulton, Andrew J. .............................Disclosed no confl ict of interest.
A817
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
Boulton, David W. ...............................Employee: Bristol-Myers Squibb Company; Stock/ Breen, Tracy .........................................Disclosed no confl ict of interest.
Shareholder: Bristol-Myers Squibb Company. Breiner, Ari ..........................................Disclosed no confl ict of interest.
Boulton, Michael E. .............................Disclosed no confl ict of interest. Brennan, Meghan ...............................Disclosed no confl ict of interest.
Boulware, David ..................................Disclosed no confl ict of interest. Brennand, Cath ...................................Disclosed no confl ict of interest.
Bounthavong, Mark ............................Disclosed no confl ict of interest. Brenner, Jeffrey ..................................Disclosed no confl ict of interest.
Bousboulas, Stavros ...........................Disclosed no confl ict of interest. Brenner, Kathy .....................................Disclosed no confl ict of interest.
Bouskela, Eliete ...................................Disclosed no confl ict of interest. Brenner, Michael B. ............................Disclosed no confl ict of interest.
Boutchueng-Djidjou, Martial .............Disclosed no confl ict of interest. Brent, Michael .....................................Disclosed no confl ict of interest.
Bouw, René .........................................Employee: AstraZeneca Pharmaceuticals LP. Brethauer, Stacy A. .............................Disclosed no confl ict of interest.
Bouziana, Stella ..................................Disclosed no confl ict of interest. Breton, Marc D. ...................................Research Support: Animas Corporation, Dexcom, Inc.,
Bouzidi, Amira .....................................Employee: Novo Nordisk A/S. Insulet Corporation, Sanofi U.S., Tandem Diabetes
Bove, Gerald ........................................Disclosed no confl ict of interest. Care, Inc.; Speaker’s Bureau: Bayer HealthCare, Roche
Bowden, Donald W. ............................Disclosed no confl ict of interest. Diagnostics, Sanofi U.S.
Bowen, Michael E. ..............................Disclosed no confl ict of interest. Brett, Jason .........................................Employee: Novo Nordisk Inc.; Stock/Shareholder: Novo
Bowering, Keith ..................................Advisory Panel: AstraZeneca, Boehringer Ingelheim, Eli Nordisk Inc.
Lilly, Johnson & Johnson, Merck, Novo Nordisk; Brewer, Amy ........................................Disclosed no confl ict of interest.
Consultant: Eli Lilly, Merck; Research Support: Eli Lilly, Brey, Eric ..............................................Disclosed no confl ict of interest.
Novo Nordisk; Speaker’s Bureau: AstraZeneca, Eli Lilly,, Bridges, Jamie ....................................Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &
Merck, Novo Nordisk. Co., Inc.
Bowers, Daniel T. ................................Disclosed no confl ict of interest. Bridges, Melissa .................................Disclosed no confl ict of interest.
Bowlby, Deborah .................................Disclosed no confl ict of interest. Briggs Early, Kathaleen ......................Disclosed no confl ict of interest.
Bowskill, Bridgit B. ..............................Disclosed no confl ict of interest. Briggs, Andrew ...................................Advisory Panel: Eli Lilly and Company; Consultant:
E
R Bowyer, Vicky ......................................Disclosed no confl ict of interest. AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb
U Boye Knudsen, Carsten ......................Disclosed no confl ict of interest. Company, GlaxoSmithKline, Sanofi .
S
Boye, Kristina S. ..................................Employee: Eli Lilly and Company, Eli Lilly and Company Brightwell-Conrad, Angela ................Employee: Metabolic Solutions Development Company, LLC.
O
L (Spouse/Partner); Stock/Shareholder: Eli Lilly and Bril, Fernando ......................................Disclosed no confl ict of interest.
C Company, Eli Lilly and Company (Spouse/Partner). Bril, Vera ..............................................Disclosed no confl ict of interest.
S
I Boyko, Edward J. ................................Disclosed no confl ict of interest. Brinton, John T. ...................................Disclosed no confl ict of interest.
D Boyle, Karen D. ....................................Disclosed no confl ict of interest. Brioschi, Marcos L. .............................Disclosed no confl ict of interest.
R Boyle, Kristen ......................................Disclosed no confl ict of interest. Brismar, Kerstin ...................................Other Relationship: AstraZeneca Pharmaceuticals LP, Eli
O
H Boyle, Luke D. ......................................Disclosed no confl ict of interest. Lilly and Company, Novo Nordisk Inc., Sanofi U.S.
T Boyle, Peter .........................................Disclosed no confl ict of interest. Brito, Gilberto N. .................................Disclosed no confl ict of interest.
U Boynton, Grace E. ................................Disclosed no confl ict of interest. Britton, Steven L. ................................Disclosed no confl ict of interest.
A Boza, Lorenzo C. ..................................Disclosed no confl ict of interest. Brixen, Kim ..........................................Disclosed no confl ict of interest.
Bozadjieva, Nadejda ...........................Disclosed no confl ict of interest. Broca, Christophe ...............................Disclosed no confl ict of interest.
Bozadjieva, Nadia ...............................Disclosed no confl ict of interest. Brock, Birgitte .....................................Board Member: Allergan, Inc., Novo Nordisk A/S; Research
Boz˙towicz-Wikarek, Maria .................Disclosed no confl ict of interest. Support: Novo Nordisk A/S; Speaker’s Bureau: Pfi zer Inc.
Bozkurt, Latife .....................................Disclosed no confl ict of interest. Brock, Christina ...................................Research Support: Novo Nordisk A/S.
Boztepe, Harika ...................................Disclosed no confl ict of interest. Brock, Ricky .........................................Disclosed no confl ict of interest.
Bozzetto, Lutgarda ..............................Disclosed no confl ict of interest. Brod, Meryl ..........................................Consultant: Novo Nordisk A/S.
Brabant, Marie-Josée ........................Employee: IMS Brogan; Research Support: GlaxoSmithKline. Broderick, Tom L. .................................Disclosed no confl ict of interest.
Bracy, Deanna P. ..................................Disclosed no confl ict of interest. Brodovicz, Kimberly G. .......................Employee: Merck & Co., Inc.; Stock/Shareholder: Merck &
Bradfi eld, Jonathan P. .........................Disclosed no confl ict of interest. Co., Inc.
Bradford, Claire M. .............................Disclosed no confl ict of interest. Broedl, Uli C. ........................................Employee: Boehringer Ingelheim GmbH.
Bradley, Paige K. .................................Disclosed no confl ict of interest. Broholm, Christa .................................Disclosed no confl ict of interest.
Brady, Cassandra C. ............................Disclosed no confl ict of interest. Broichhagen, Johannes ......................Disclosed no confl ict of interest.
Brændgaard, Hans ..............................Disclosed no confl ict of interest. Brokaw, Sarah .....................................Disclosed no confl ict of interest.
Braffett, Barbara H. ............................Disclosed no confl ict of interest. Bron-Green, Morgan ...........................Employee: Owns company granted stocks and long term
Bragg, Fiona ........................................Disclosed no confl ict of interest. incentives, Takeda Pharmaceuticals U.S.A., Inc.
Brahma, Manoja K. .............................Disclosed no confl ict of interest. Brøns, Charlotte ..................................Stock/Shareholder: Novo Nordisk A/S.
Bramlage, Peter ..................................Advisory Panel: AstraZeneca Pharmaceuticals LP, Bristol- Brookhart, Alan M. .............................Disclosed no confl ict of interest.
Myers Squibb Company, Takeda Pharmaceutical Brooks, Augustin .................................Disclosed no confl ict of interest.
Company Limited; Consultant: AstraZeneca Brooks, Belinda A. ...............................Disclosed no confl ict of interest.
Pharmaceuticals LP, Berlin-Chemie AG, Bristol-Myers Brøsen, Kim .........................................Disclosed no confl ict of interest.
Squibb Company, Eli Lilly and Company, Novartis Brosius, Frank C. .................................Disclosed no confl ict of interest.
Pharma GmbH, Takeda Pharmaceutical Company Brosnan, Julia .....................................Employee: Pfi zer Inc.
Limited. Broughton, Terri ..................................Disclosed no confl ict of interest.
Brancato, Davide ................................Disclosed no confl ict of interest. Brown, Adam S. ..................................Disclosed no confl ict of interest.
Brandon, Amanda E. ...........................Disclosed no confl ict of interest. Brown, Alex .........................................Disclosed no confl ict of interest.
Brandt, Ann-Sofi e ...............................Employee: Medtronic, Inc. Brown, Alison ......................................Disclosed no confl ict of interest.
Brandt, Nicole .....................................Disclosed no confl ict of interest. Brown, Eric ..........................................Disclosed no confl ict of interest.
Brangani, Corinna ...............................Disclosed no confl ict of interest. Brown, Florence M. ............................Disclosed no confl ict of interest.
Branigan, Michelle ..............................Disclosed no confl ict of interest. Brown, Jennifer J. ..............................Disclosed no confl ict of interest.
Brannon, Marianne F. ..........................Disclosed no confl ict of interest. Brown, Kyle .........................................Research Support: AstraZeneca Pharmaceuticals LP.
Brantley, Phillip ...................................Disclosed no confl ict of interest. Brown, Mark ........................................Disclosed no confl ict of interest.
Brath, Helmut ......................................Advisory Panel: Eli Lilly & Co., Novo Nordisk, Boehringer Brown, Melissa ...................................Disclosed no confl ict of interest.
Ingelheim, Novartis, Sanofi , AstraZeneca, Merck & Co., Brown, Rebecca J. ..............................Disclosed no confl ict of interest.
Takeda, Janssen-Cilag; Speaker’s Bureau: Eli Lilly & Co., Brown, Sue A. .....................................Research Support: Animas Corporation, Dexcom, Inc.,
Novo Nordisk, Boehringer Ingelheim, Novartis, Sanofi , Medtronic, Inc., Roche Diagnostics.
AstraZeneca, Merck & Co., Takeda, Janssen-Cilag, Brown, Susan D. ..................................Disclosed no confl ict of interest.
Servier. Browne, Jessica L. ..............................Consultant: Roche Diagnostics Australia, Sanofi Australia;
Braun, Kathryn ....................................Disclosed no confl ict of interest. Research Support: AstraZaneca Australia, Sanofi
Braunwald, Eugene .............................Research Support: AstraZeneca Pharmaceuticals LP, Bristol- Australia.
Myers Squibb Company. Brown-Kerr, Alana G. ..........................Disclosed no confl ict of interest.
Bray, George ........................................Disclosed no confl ict of interest. Brozinick, Joseph T. ............................Disclosed no confl ict of interest.
Brayman, Kenneth L. ...........................Disclosed no confl ict of interest. Brubaker, Patricia L. ............................Research Support: Novo Nordisk A/S.
Brazg, Ronald ......................................Research Support: PhaseBio Pharmaceuticals, Inc. Bruckbauer, Antje ...............................Employee: NuSirt Biopharma.
Brazier, John E. ....................................Consultant: Novo Nordisk A/S. Brudno, Yevgeny .................................Disclosed no confl ict of interest.
Bréant, Bernadette .............................Disclosed no confl ict of interest. Brüggemann, Jutta .............................Disclosed no confl ict of interest.
Breault, David .....................................Disclosed no confl ict of interest. Bruke, George W. ................................Disclosed no confl ict of interest.
Breen, Gerome ....................................Research Support: National Institute for Health Research Brulle-Wohlhueter, Claire ...................Employee: Sanofi .
Biomedical Research Centre for Mental Health. Brumfeld, Alexandria ..........................Disclosed no confl ict of interest.
A818
AUTHOR RELATIONSHIP/COMPANY AUTHOR RELATIONSHIP/COMPANY
Brun, Alex ............................................Employee: AstraZeneca Pharmaceuticals LP. Bursill, Christina ..................................Disclosed no confl ict of interest.
Brunak, Søren ......................................Disclosed no confl ict of interest. Burtman, Elizabeth .............................Disclosed no confl ict of interest.
Brüning, Jens C. ..................................Disclosed no confl ict of interest. Burton, Jeffrey H. ...............................Disclosed no confl ict of interest.
Brunner, Eric ........................................Disclosed no confl ict of interest. Burtt, Noël ...........................................Disclosed no confl ict of interest.
Brunner, Martina .................................Disclosed no confl ict of interest. Busch, Robert S. ..................................Advisory Panel: Janssen Pharmaceutical Companies
Bruno, Antonio ....................................Disclosed no confl ict of interest. of Johnson & Johnson, Merck & Co., Inc., Sanofi
Bruno, Graziella ...................................Disclosed no confl ict of interest. U.S.; Employee: VMS Biomarketing (Spouse/
Bruno, Joanne H. .................................Disclosed no confl ict of interest. Partner); Research Support: Abbvie, AstraZeneca
Brunt, Jara J. .......................................Disclosed no confl ict of interest. Pharmaceuticals LP, Eisai Co., Ltd., Eli Lilly and
Brusko, Todd M. ..................................Disclosed no confl ict of interest. Company, Novo Nordisk Inc.; Speaker’s Bureau:
Brustman, Lois ....................................Disclosed no confl ict of interest. AstraZeneca Pharmaceuticals LP, Eisai Co., Ltd., Eli
Brutsaert, Erika F. ...............................Disclosed no confl ict of interest. Lilly and Company, Janssen Pharmaceutical Companies
Bruttomesso, Daniela .........................Advisory Panel: Abbott Diabetes Care, Inc.; Speaker’s of Johnson & Johnson, Novo Nordisk Inc., Takeda
Bureau: Eli Lilly and Company, LifeScan, Inc., Roche Pharmaceuticals U.S.A., Inc.
Diagnostics, Sanofi U.S. Buschard, Karsten ...............................Disclosed no confl ict of interest.
Bruzzese, Mariella ..............................Disclosed no confl ict of interest. Busciglio, Jorge ...................................Disclosed no confl ict of interest.
Bry, Lynn ..............................................Disclosed no confl ict of interest. Buse, John B. .......................................Consultant: PhaseBio Pharmaceuticals, Inc.;
Brzozowska, Aniceta ..........................Disclosed no confl ict of interest. Other Relationship: Andromeda, AstraZeneca
Bu, Le ...................................................Disclosed no confl ict of interest. Pharmaceuticals LP, Boehringer Ingelheim GmbH,
Bu, Shi ..................................................Disclosed no confl ict of interest. Bristol-Myers Squibb Company, Elcelyx Therapeutics,
Buanes, Trond ......................................Disclosed no confl ict of interest. Inc., Eli Lilly and Company, F. Hoffmann-La Roche,
Bucci, John ..........................................Employee: Life Technologies - manufacturer of microarays Ltd., GI Dynamics, Inc., GlaxoSmithKline, Halozyme
E
used in study. Therapeutics, Intarcia Therapeutics, Inc., Johnson & R
Buchanan, Thomas A. .........................Disclosed no confl ict of interest. Johnson, Lexicon Pharmaceuticals, Inc., LipoScience, U
S
Bucheli, Jose R. ...................................Disclosed no confl ict of interest. Inc., Medtronic, Inc., Merck & Co., Inc., Metabolon,
O
Buchwald, Peter ..................................Disclosed no confl ict of interest. Inc., Metavention, Novo Nordisk A/S, Orexigen L
Buckeridge, Clare ................................Employee: Pfi zer Inc. Therapeutics, Inc., Osiris Therapeutics, Inc., Pfi zer Inc., C
S
Buckingham, Bruce A. ........................Advisory Panel: Animas Corporation, BD Medical-Diabetes PhaseBio Pharmaceuticals, Inc., Quest Diagnostics, I
Care, Halozyme Therapeutics, Medtronic MiniMed, Rhythm Pharmaceuticals, Sanofi U.S., Spherix Inc., D
Inc., Novo Nordisk Inc., Sanofi U.S., Tandem Diabetes Takeda Pharmaceutical Company Limited, ToleTx, R
O
Care, Inc.; Research Support: Dexcom, Inc. TransTech Pharma, LLC.; Stock/Shareholder: PhaseBio H
Buckley, Stephen T. .............................Employee: Novo Nordisk A/S. Pharmaceuticals, Inc. T
Buckman, Melanie ..............................Disclosed no confl ict of interest. Busha, Ryan .........................................Disclosed no confl ict of interest. U
Buday, Barbara ....................................Disclosed no confl ict of interest. Bushinsky, David .................................Consultant: Relypsa, Inc.; Stock/Shareholder: Relypsa, Inc. A
Budiman-Mak, Elly ..............................Disclosed no confl ict of interest. Busik, Julia ..........................................Disclosed no confl ict of interest.
Buettner, Christoph .............................Disclosed no confl ict of interest. Busjahn, Andreas ................................Disclosed no confl ict of interest.
Bue-Valleskey, Juliana .......................Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly Butcher, Marcene ...............................Disclosed no confl ict of interest.
and Company. Buteau, Jean .......................................Disclosed no confl ict of interest.
Buffolo, Márcio ...................................Disclosed no confl ict of interest. Butler, Deborah A. ..............................Disclosed no confl ict of interest.
Bugliani, Marco ...................................Disclosed no confl ict of interest. Butler, Kenneth ...................................Disclosed no confl ict of interest.
Buhl, Thora ..........................................Disclosed no confl ict of interest. Butler, Melissa G. ...............................Research Support: Novartis Corporation.
Bui, Hai .................................................Disclosed no confl ict of interest. Butner, Jonathan E. ............................Research Support: National Institute of Diabetes and
Bui, Nancy ...........................................Disclosed no confl ict of interest. Digestive and Kidney Diseases.
Bull, Shelley B. ....................................Disclosed no confl ict of interest. Butrico, Gina ........................................Disclosed no confl ict of interest.
Bullano, Michael .................................Employee: AstraZeneca Pharmaceuticals LP. Butros, Fady T. .....................................Employee: Eli Lilly and Company; Stock/Shareholder: Eli Lilly
Bullard, Kai M. .....................................Disclosed no confl ict of interest. and Company.
Buller, R. Mark L. .................................Disclosed no confl ict of interest. Butte, Atul ...........................................Disclosed no confl ict of interest.
Bulotta, Angela ...................................Employee: Novo Nordisk Inc. Butterworth, Martha ..........................Disclosed no confl ict of interest.
Bülow, Jens .........................................Disclosed no confl ict of interest. Büttner, Petra ......................................Disclosed no confl ict of interest.
Bulum, Tomislav ..................................Disclosed no confl ict of interest. Buxton, Joanne ...................................Disclosed no confl ict of interest.
Bun, Socheath .....................................Disclosed no confl ict of interest. Buysman, Erin K. .................................Other Relationship: Janssen Pharmaceutical Companies of
Bunker, Clareann .................................Disclosed no confl ict of interest. Johnson & Johnson.
Buranasupkajorn, Patinut ...................Disclosed no confl ict of interest. Buzea, Mihaela ...................................Disclosed no confl ict of interest.
Burant, Charles F. ................................Consultant: Zydus Research Centre, Cadila Healthcare Buzzetti, Raffaella ..............................Disclosed no confl ict of interest.
Limited, Ahmedabad, India. Bychkova, Ielizaveta ...........................Disclosed no confl ict of interest.
Burch, Miguel ......................................Research Support: GI Dynamics, Inc. Byerly, Sara J. .....................................Disclosed no confl ict of interest.
Burda, Vaclav .......................................Disclosed no confl ict of interest. Byers, Joyce ........................................Disclosed no confl ict of interest.
Burg, Ashley R. ....................................Disclosed no confl ict of interest. Bynoe, Karen A. ..................................Disclosed no confl ict of interest.
Burge, Mark R. ....................................Research Support: Research Study, Unrelated, Sanofi U.S. Bytoft, Birgitte ....................................Disclosed no confl ict of interest.
Burgeiro, Ana ......................................Disclosed no confl ict of interest. Byun, Dongwon ...................................Disclosed no confl ict of interest.
Burger, Douglas ...................................Disclosed no confl ict of interest. Caan, Matthan W. ...............................Disclosed no confl ict of interest.
Burgess, Jenna E. ...............................Disclosed no confl ict of interest. Caballero, A. Enrique ..........................Disclosed no confl ict of interest.
Burgess, Shawn C. ..............................Disclosed no confl ict of interest. Caballero-Ruiz, Estefanía ...................Disclosed no confl ict of interest.
Burgos, Sergio A. ................................Disclosed no confl ict of interest. Cabrera, Over ......................................Employee: Eli Lilly and Company.
Burguera, Bartolome ..........................Disclosed no confl ict of interest. Cabrera, Susanne M. ..........................Disclosed no confl ict of interest.
Burguete, Ana I. ..................................Disclosed no confl ict of interest. Cabzuca, Carolina ...............................Disclosed no confl ict of interest.
Buring, Julie E. ....................................Disclosed no confl ict of interest. Caccioppoli, Cristina ...........................Disclosed no confl ict of interest.
Burk, David ..........................................Disclosed no confl ict of interest. Cade, Brian ..........................................Disclosed no confl ict of interest.
Burkart, Alison ....................................Disclosed no confl ict of interest. Caetano, Lilian A. ................................Disclosed no confl ict of interest.
Burkart, Volker ....................................Disclosed no confl ict of interest. Cahn, Avivit .........................................Advisory Panel: Boehringer Ingelheim Pharmaceuticals,
Burke III, George W. ............................Disclosed no confl ict of interest. Inc., Novo Nordisk Inc., Sanofi U.S.; Speaker’s Bureau:
Burkhardt, Brant R. .............................Disclosed no confl ict of interest. AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim
Burkhardt, Ralph .................................Disclosed no confl ict of interest. Pharmaceuticals, Inc., Merck Sharp & Dohme, Novartis
Burlina, Silvia ......................................Disclosed no confl ict of interest. Pharmaceuticals Corporation, Novo Nordisk Inc., Sanofi
Burmeister, Melissa A. .......................Disclosed no confl ict of interest. U.S., Teva Pharmaceutical Industries Ltd.
Burnet, Deborah L. ..............................Disclosed no confl ict of interest. Cahn, Frederick ...................................Consultant: Freedom Meditech, Inc.
Burns, Colleen .....................................Employee: Elcelyx Therapeutics, Inc. Cai, Beilei .............................................Employee: Boehringer Ingelheim Pharmaceuticals, Inc.
Burns, Kharis .......................................Disclosed no confl ict of interest. Cai, Erica P. ..........................................Disclosed no confl ict of interest.
Burnside, Amy .....................................Disclosed no confl ict of interest. Cai, Jinjin .............................................Disclosed no confl ict of interest.
Burrell, Louise M. ................................Disclosed no confl ict of interest. Cai, Lu ..................................................Disclosed no confl ict of interest.
Burris, Marcie ......................................Disclosed no confl ict of interest. Cai, Mona ............................................Disclosed no confl ict of interest.
Burrows, Nilka R. ................................Disclosed no confl ict of interest. Cai, Qin .................................................Employee: Novartis Pharmaceuticals Corporation.
A819